Processing 00000000.tx.1: Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus M. 

Phrase: "Experimental models of systemic lupus erythematosus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086272:Models, Experimental [Intellectual Product]
   753   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in murine lupus M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Blank1 and Y. 

Phrase: "Blank1"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.3: Shoenfeld1,2 1 Department of Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine and 2 Incumbent of the Laura SchwartzKipp chair for Autoimmunity, Tel Aviv University, Israel. 

Phrase: "Shoenfeld1,"

Phrase: "2 1 Department of Medicine B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "The Center for Autoimmune Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "Sheba Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Tel Hashomer,"

Phrase: "Sackler Faculty of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015535:Faculty [Professional or Occupational Group]

Phrase: "and"

Phrase: "2 Incumbent of the Laura SchwartzKipp chair"

Phrase: "for Autoimmunity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "Tel Aviv University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: "Israel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]
Processing 00000000.tx.4: Correspondence to: Y. 

Phrase: "Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Y."
Processing 00000000.tx.5: Shoenfeld, Department of Medicine B and Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel 52621. 

Phrase: "Shoenfeld,"

Phrase: "Department of Medicine B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Center for Autoimmune Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Sheba Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Tel Hashomer,"

Phrase: "Israel 52621."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022271:Israel [Geographic Area]
Processing 00000000.tx.6: E-mail: shoenfel{at}post.tau.ac.il The aim of this editorial is to highlight the need for further insight into the network cascade leading to diverse serological, clinical and inflammatory manifestations and multiple organ damage in lupus, associated with anti-double-stranded DNA (anti-dsDNA) antibodies. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "shoenfel{at}post.tau.ac.il"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0020898:IL [Geographic Area]
   799   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0022271:IL [Geographic Area]

Phrase: "The aim of this editorial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "highlight"

Phrase: "the need for further insight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027552:Need [Qualitative Concept]
   760   C0686904:need [Functional Concept]

Phrase: "into the network cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707310:Cascade [Manufactured Object]

Phrase: "leading to diverse serological, clinical"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0205473:Serological [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1880371:Diverse [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inflammatory manifestations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205319:manifestations [Functional Concept]
   861   C1280464:manifestations [Qualitative Concept]

Phrase: "and"

Phrase: "multiple organ damage in lupus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010957:Damage [Injury or Poisoning]
   760   C0178784:Organ [Body Part, Organ, or Organ Component]
   760   C1883709:Damage [Functional Concept]

Phrase: "associated with anti-double-stranded DNA (anti-dsDNA) antibodies."
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.7: Better understanding of the lupus network may serve as a basis to develop specific targeted therapy based on lessons from experimental lupus models. 

Phrase: "Better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "understanding of the lupus network"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0024131:Lupus [Disease or Syndrome]
   760   C0024138:lupus [Disease or Syndrome]
   760   C0162340:Understanding [Mental Process]
   760   C0409974:Lupus [Disease or Syndrome]
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: "may"

Phrase: "serve as a basis to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "develop"

Phrase: "specific targeted therapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2985566:Targeted Therapy [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]

Phrase: "based on lessons"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from experimental lupus models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0086272:Models, Experimental [Intellectual Product]
   827   C3161035:Models [Intellectual Product]
Processing 00000000.tx.8: Systemic lupus erythematosus (SLE) is an autoimmune disease of multifactorial etiology and diverse mechanisms. 

Phrase: "Systemic lupus erythematosus (SLE)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "an autoimmune disease of multifactorial etiology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004364:Autoimmune Disease [Disease or Syndrome]
   783   C1314792:disease etiology [Functional Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0443146:Autoimmune [Pathologic Function]

Phrase: "and"

Phrase: "diverse mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.9: Although the disease is T-cell-dependent and antigen-driven, more than 100 autoantibodies were detected in the sera of lupus patients with differential correlation to disease activity [1, 2]. 

Phrase: "Although"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "T-cell-dependent"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0039194:T-cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1701901:Dependent [Qualitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "antigen-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: ","

Phrase: "more than 100 autoantibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0205172:More [Functional Concept]

Phrase: "were"

Phrase: "detected in the sera of lupus patients"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0024131:Lupus [Disease or Syndrome]
   748   C0024138:lupus [Disease or Syndrome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0229671:Sera [Body Substance]
   748   C0409974:Lupus [Disease or Syndrome]
   748   C0442726:Detected [Finding]
   748   C1151254:SerA [Molecular Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   714 E C1546774:Serum [Intellectual Product]
   714 E C1550100:Serum [Body Substance]

Phrase: "with differential correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "to disease activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "]."
Processing 00000000.tx.10: Many of the current autoantigen targets are derived from macromolecular structures such as chromatin (nucleosomes composed of dsDNA and histones), and small nuclear ribonucleoproteins (snRNPs) [3]. 

Phrase: "Many of the current autoantigen targets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004359:Autoantigen [Immunologic Factor]
   753   C0439064:Many [Quantitative Concept]
   753   C0521116:Current [Temporal Concept]
   753   C0747726:many [Conceptual Entity]
   753   C1705970:Current [Natural Phenomenon or Process]
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]

Phrase: "are"

Phrase: "derived from macromolecular structures"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0026383:Macromolecular Structure [Molecular Sequence]
   770   C0678594:structures [Spatial Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   742 E C1373089:Structural Macromolecules [Molecular Function]

Phrase: "such as chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "(nucleosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028623:Nucleosomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1166675:nucleosome [Cell Component]

Phrase: "composed of dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "histones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019652:Histones [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "small nuclear ribonucleoproteins (snRNPs)"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0142661:Small Nuclear Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1167162:small nuclear ribonucleoprotein [Cell Component]
   827   C0035544:Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0700321:Small [Quantitative Concept]
   793 E C1167298:ribonucleoprotein [Cell Component]

Phrase: "[3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "]."
Processing 00000000.tx.11: Using lupus-prone mice [(NZBxNZW)F1(BWF1) or (SWRxNZB)F1(SNF1)], Mohan et al. showed that the nucleosome is the major immunogen for pathogenic autoantibody-inducing T-cells [4]. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lupus-prone mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "["

Phrase: "(NZBxNZW"

Phrase: ")"

Phrase: "F1(BWF1"

Phrase: ")"

Phrase: "or (SWRxNZB"

Phrase: ")"

Phrase: "F1(SNF1"

Phrase: ")"

Phrase: "],"

Phrase: "Mohan et al."

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the nucleosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028623:Nucleosome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166675:nucleosome [Cell Component]

Phrase: "is"

Phrase: "the major immunogen for pathogenic autoantibody-inducing T-cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003320:Immunogen [Immunologic Factor]

Phrase: "[4"

Phrase: "]."
Processing 00000000.tx.12: Moreover, synthetic peptide localized in the critical autoepitopes for lupus nephritis-inducing Th cells had a tolerogenic potential [5]. 

Phrase: "Moreover,"

Phrase: "synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "localized in the critical autoepitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392752:Localized [Spatial Concept]
   760   C1511545:Critical [Qualitative Concept]

Phrase: "for lupus nephritis-inducing Th cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   823   C0018894:Th cell [Cell]
   812   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "a tolerogenic potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "[5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.13: The self macromolecules are normally sequestered from the immune system by virtue of their intracellular location, but can become more accessible to the immune system as a result of cell necrosis or apoptosis [6, 7]. 

Phrase: "The self macromolecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "normally"

Phrase: "sequestered from the immune system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0020962:Immune system [Body System]
   806   C1291764:IMMUNE SYSTEM [Finding]
   760   C0333312:Sequestered [Functional Concept]
   760   C0439662:Immune [Functional Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "by virtue of their intracellular location,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "but"

Phrase: "can"

Phrase: "become"

Phrase: "more accessible to the immune system"

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of cell necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]

Phrase: "or"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "[6,"

Phrase: "7"

Phrase: "]."
Processing 00000000.tx.14: Such accessibility can result from migration to apoptotic blebs and release into the extracellular environment. 

Phrase: "Such accessibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814423:accessibility [Qualitative Concept]

Phrase: "can"

Phrase: "result from migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0600210:Migration [Social Behavior]
   790   C1274040:Result [Functional Concept]
   790   C1533574:Migration [Physiologic Function]
   790   C1546471:Result [Idea or Concept]
   790   C1881827:MIGRATION [Phenomenon or Process]
   790   C2825142:Result [Finding]

Phrase: "to apoptotic blebs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0005758:Blebs [Pathologic Function]
   827 E C1820376:bleb [Cell Component]

Phrase: "and"

Phrase: "release into the extracellular environment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.15: Furthermore, biochemical modifications can be induced by apoptotic effector mechanisms, cell injury and post-translational modifications such as oxidation and phosphorylation. 

Phrase: "Furthermore,"

Phrase: "biochemical modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "induced by apoptotic effector mechanisms,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205263:Induced [Functional Concept]
   760   C0441712:Mechanisms [Functional Concept]
   760   C1516044:Apoptotic [Qualitative Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "cell injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599732:cell injury [Cell or Molecular Dysfunction]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "post-translational modifications such as oxidation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1704687:Post [Manufactured Object]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.16: (ii) Attempts to repair such lesions, can create neo-epitopes and induce immunogenicity [8, 9]. 

Phrase: "(ii"

Phrase: ")"

Phrase: "Attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "such lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0221198:lesions [Finding]
   966 E C1546698:Lesion [Intellectual Product]

Phrase: "can"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "neo-epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003316:Epitopes [Immunologic Factor]
   861   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "immunogenicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0872192:immunogenic [Functional Concept]
   900 E C0003320:Immunogen [Immunologic Factor]

Phrase: "[8,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.17: Several lines of evidence suggest a role for apoptotic cells in the induction of autoimmunity. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.18: Injection of a large number of apoptotic cells into naive mice evoked generation of autoantibodies to nuclear antigens [10]. 

Phrase: "Injection of a large number of apoptotic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "into naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "generation of autoantibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "to nuclear antigens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0069115:Antigens, Nuclear [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   861   C0521447:Nuclear [Spatial Concept]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "[10"

Phrase: "]."
Processing 00000000.tx.19: The defects in Fas and FasL respectively result in incomplete elimination of peripheral autoreactive cells as this elimination occurs predominantly by Fas-mediated apoptosis [11, 12]. 

Phrase: "The defects in Fas"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "FasL respectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0253023:Fas-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1515370:Fas-L [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "result in incomplete elimination of peripheral autoreactive cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0007634:Cells [Cell]
   744   C0205100:Peripheral [Spatial Concept]
   744   C0205257:Incomplete [Quantitative Concept]
   744   C0221102:Elimination [Physiologic Function]
   744   C0728938:incomplete [Quantitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1548386:incomplete [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "as this elimination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221102:Elimination [Physiologic Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "predominantly by Fas-mediated apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0162638:Apoptosis [Cell Function]

Phrase: "[11,"

Phrase: "12"

Phrase: "]."
Processing 00000000.tx.20: Injection of soluble Fas into naive mice protected from the development of autoimmune features due to blocking of Fas-induced apoptosis [13]. 

Phrase: "Injection of soluble Fas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "into naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "protected from the development of autoimmune features"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243107:development [Physiologic Function]
   748   C0443146:Autoimmune [Pathologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "due to"

Phrase: "blocking of Fas-induced apoptosis"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0162638:Apoptosis [Cell Function]
   760   C0205263:Induced [Functional Concept]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.21: An increased rate of apoptosis and decreased clearance of apoptotic cells have been demonstrated in SLE animal models and patients [1418]. 

Phrase: "An increased rate of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "decreased clearance of apoptotic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1523908:apoptotic cell clearance [Cell Function]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated in SLE animal models"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   814   C2984317:Systemic lupus erythematosus [Functional Concept]
   778   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   778   C0599779:Models, Animal [Animal]
   748   C0003062:Animal [Animal]
   748   C0024131:Lupus [Disease or Syndrome]
   748   C0024138:lupus [Disease or Syndrome]
   748   C0205373:Systemic [Functional Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "[1418"

Phrase: "]."
Processing 00000000.tx.22: Recently, a deficiency of CD226 and survivin (anti-apoptotic member protein) in NK T cells from active SLE was suggested to be the molecular basis of a high sensitivity of the cells to anti-CD95-induced apoptosis [19]. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a deficiency of CD226"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "and"

Phrase: "survivin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0664336:survivin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332416:SURVIVIN [Gene or Genome]
  1000   C1705785:Survivin [Gene or Genome]

Phrase: "(anti-apoptotic member protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in NK T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0022688:NK Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "from active SLE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   923   C2984317:Systemic lupus erythematosus [Functional Concept]
   861   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   812   C0024131:Lupus [Disease or Syndrome]
   812   C0024138:lupus [Disease or Syndrome]
   812   C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the molecular basis of a high sensitivity of the cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1853126:MOLECULAR BASIS [Idea or Concept]
   739   C1527178:Basis [Functional Concept]
   739   C1874451:Basis [Pharmacologic Substance]

Phrase: "to anti-CD95-induced apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C1512772:anti-apoptosis [Cell Function]
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "[19"

Phrase: "]."
Processing 00000000.tx.23: The immunogenic potential of nuclear antigens exposed during apoptosis, together with considerable animal data, suggests that impaired apoptotic clearance can result in systemic lupus SLE-like autoimmunity and supports the idea that self-immunization with apoptotic debris may be one of the major driving mechanisms in lupus. 

Phrase: "The immunogenic potential of nuclear antigens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "exposed during apoptosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C0332157:Exposed [Clinical Attribute]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "together with considerable animal data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0597710:animal data [Intellectual Product]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired apoptotic clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "can"

Phrase: "result in systemic lupus SLE-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   804   C2984317:Systemic lupus erythematosus [Functional Concept]
   774   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   748   C0024131:Lupus [Disease or Syndrome]
   748   C0024138:lupus [Disease or Syndrome]
   748   C0205373:Systemic [Functional Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "like autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "and"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that self-immunization with apoptotic debris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C3244291:immunization [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "one of the major driving mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in lupus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024131:Lupus [Disease or Syndrome]
  1000   C0024138:lupus [Disease or Syndrome]
  1000   C0409974:Lupus [Disease or Syndrome]
Processing 00000000.tx.24: The multiple roles of complement receptors, diverse scavenger receptors, phosphatidylserine-specific receptor and intermediate proteins (CRP, SAP, -2-glycoprotein-I) that bind to and opsonize apoptotic cells indicate a complex web of interactions leading to the clearance of apoptotic debris. 

Phrase: "The multiple roles of complement receptors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "diverse scavenger receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0074129:Receptors, Scavenger [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017108:scavenger [Medical Device]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1003377:scavenger [Fish]

Phrase: "phosphatidylserine-specific receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0914267:phosphatidylserine receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C1426187:PHOSPHATIDYLSERINE RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "intermediate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(CRP,"

Phrase: "SAP, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420017:SAP [Gene or Genome]
  1000   C1456795:SAP [Gene or Genome]
  1000   C2699241:SAP [Gene or Genome]
  1000   C2700633:Sap [Plant]

Phrase: "2-glycoprotein-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "that"

Phrase: "bind to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1145667:Bind [Activity]
   833   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "opsonize"

Phrase: "apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "indicate"

Phrase: "a complex web of interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282111:Web [Manufactured Object]

Phrase: "leading to the clearance of apoptotic debris."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0332152:Leading [Temporal Concept]
   748   C0440266:Debris [Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1516044:Apoptotic [Qualitative Concept]
   748   C1522538:Leading [Functional Concept]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.25: Disturbances in parts of this system may lead to lupus or to lupus exacerbations. 

Phrase: "Disturbances in parts of this system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2699787:Disturbance [Qualitative Concept]

Phrase: "may"

Phrase: "lead to lupus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0024131:Lupus [Disease or Syndrome]
   790   C0024138:lupus [Disease or Syndrome]
   790   C0409974:Lupus [Disease or Syndrome]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or to lupus exacerbations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024131:Lupus [Disease or Syndrome]
   770   C0024138:lupus [Disease or Syndrome]
   770   C0409974:Lupus [Disease or Syndrome]
Processing 00000000.tx.26: Phagocytosis and clearance of apoptotic cells can be mediated by Mer, a member of the Axl/Mer/Tyro3 receptor tyrosine kinase family [20]. 

Phrase: "Phagocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]

Phrase: "and"

Phrase: "clearance of apoptotic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   870   C1523908:apoptotic cell clearance [Cell Function]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by Mer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "a member of the Axl/Mer/Tyro3 receptor tyrosine kinase family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0086282:Family member [Family Group]
   754   C1611821:Family Member [Intellectual Product]
   738   C0680022:member [Population Group]
   738   C2698041:Member [Professional or Occupational Group]

Phrase: "[20"

Phrase: "]."
Processing 00000000.tx.27: Merkd mice with a cytoplasmic truncation of Mer had macrophages deficient in the specific clearance of apoptotic thymocytes [20]. 

Phrase: "Merkd mice with a cytoplasmic truncation of Mer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "deficient in the specific clearance of apoptotic thymocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011155:Deficient [Functional Concept]
   744   C1636779:% deficient [Quantitative Concept]

Phrase: "[20"

Phrase: "]."
Processing 00000000.tx.28: Impaired clearance of apoptotic cells was documented in c-mer-deficient mice, which develop progressive lupus-like autoimmunity, accompanied by elevated circulating antibodies to chromatin and DNA [21]. 

Phrase: "Impaired clearance of apoptotic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1523908:apoptotic cell clearance [Cell Function]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "documented in c-mer-deficient mice,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C1636779:% deficient [Quantitative Concept]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "which"

Phrase: "develop"

Phrase: "progressive lupus-like autoimmunity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004368:Autoimmunity [Pathologic Function]
   741 E C0443146:Autoimmune [Pathologic Function]

Phrase: "accompanied by elevated circulating antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0175630:Circulating [Functional Concept]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[21"

Phrase: "]."
Processing 00000000.tx.29: Others pointed to the consequence of altered opsonization of apoptotic cells as a contributor to reduced removal of apoptotic cells by monocytes, and developing an autoimmune state [2225]. 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "pointed to the consequence of altered opsonization of apoptotic cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0686907:Consequence of [Functional Concept]
           Consequence
   739   C0007634:Cells [Cell]
   739   C0392747:Altered [Functional Concept]
   739   C1159762:opsonization [Cell Function]
   739   C1516044:Apoptotic [Qualitative Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706   C1552961:Point [Quantitative Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   706   C2347617:point [Quantitative Concept]

Phrase: "as a contributor"

Phrase: "to reduced removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "and"

Phrase: "developing"

Phrase: "an autoimmune state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004368:Autoimmune state [Pathologic Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "[2225"

Phrase: "]."
Processing 00000000.tx.30: Serum amyloid P component (SAP) knockout mice developed antinuclear antibodies [23]. 

Phrase: "Serum amyloid P component"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0002721:Serum Amyloid P-Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P Component
           Amyloid P
  1000   C1456795:AMYLOID P COMPONENT, SERUM [Gene or Genome]
           SERUM AMYLOID P
   923   C0443856:Serum amyloid P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0607063:serum P-component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002723:serum amyloid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0229671:Serum [Body Substance]
   812   C0449432:Component [Manufactured Object]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1705248:Component [Conceptual Entity]

Phrase: "(SAP) knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "antinuclear antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0003243:Antibodies, Antinuclear [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "[23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.31: Exposure of phagocytes to SAP improved the uptake of apoptotic cells by macrophages [24]. 

Phrase: "Exposure of phagocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to SAP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420017:SAP [Gene or Genome]
  1000   C1456795:SAP [Gene or Genome]
  1000   C2699241:SAP [Gene or Genome]
  1000   C2700633:Sap [Plant]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "the uptake of apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "by macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "[24"

Phrase: "]."
Processing 00000000.tx.32: In an another report, 25% of C1q/ mice developed glomerulonephritis with immune deposits and multiple apoptotic cell bodies [25]. 

Phrase: "In an"

Phrase: "another report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "25% of C1q/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "glomerulonephritis with immune deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017658:Glomerulonephritis [Disease or Syndrome]

Phrase: "and"

Phrase: "multiple apoptotic cell bodies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   858   C3269134:apoptotic body [Cell Component]
   827   C0599444:Cell body [Cell Component]
   827   C2752549:cell body [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0242821:bodies [Human]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C1995017:Bodies [Cell Component]
   779 E C0460148:Body [Anatomical Structure]
   779 E C1268086:Body [Anatomical Structure]

Phrase: "[25"

Phrase: "]."
Processing 00000000.tx.33: One of the questions raised as a result of the defect in the clearance of apoptotic cells or altered opsonization in lupus is whether DNA may be presented as an immunogen evoking an anti-dsDNA response. 

Phrase: "One of the questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "raised as a result of the defect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0442818:Raised [Quantitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1457869:Defect [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1861101:DEFECT [Disease or Syndrome]
   748   C2825142:Result [Finding]

Phrase: "in the clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "of apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "altered opsonization in lupus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1159762:opsonization [Cell Function]

Phrase: "is"

Phrase: "whether"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "be"

Phrase: "presented as an immunogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003320:Immunogen [Immunologic Factor]
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "evoking"

Phrase: "an"

Phrase: "anti-dsDNA response."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.34: Immunization of SF1 mice with nucleosomes or its major synthetic epitope triggers Th1-type autoimmune T cells that drive production of the antinuclear, anti-dsDNA and antihistone autoantibodies associated with the clinical picture of lupus [35]. 

Phrase: "Immunization of SF1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "with nucleosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028623:Nucleosomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1166675:nucleosome [Cell Component]

Phrase: "or"

Phrase: "its major synthetic epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitope [Immunologic Factor]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "Th1-type autoimmune T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0242632:Th1 Cells [Cell]
   858   C0449475:type cell [Intellectual Product]
   840   C0039194:T-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "production of the antinuclear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "antihistone autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "associated with the clinical picture of lupus"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0024131:Lupus [Disease or Syndrome]
   748   C0024138:lupus [Disease or Syndrome]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0409974:Lupus [Disease or Syndrome]
   748   C0441468:picture [Manufactured Object]
   748   C0441469:Picture [Manufactured Object]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[35"

Phrase: "]."
Processing 00000000.tx.35: Mammalian DNA was generally considered to be non-immunogenic and unable to induce a specific response under the usual immunization conditions, including complexation with a protein carrier and administration in Freund's complete adjuvant [26, 27]. 

Phrase: "Mammalian DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "generally"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "non-immunogenic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0872192:immunogenic [Functional Concept]
   861   C1518422:Non [Functional Concept]
   789 E C0003320:Immunogen [Immunologic Factor]

Phrase: "and"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a specific response under the usual immunization conditions,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   725   C0009647:conditioned response [Mental Process]
   725   C0009649:conditional response [Mental Process]
   725   C0034936:Conditioned response [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "complexation with a protein carrier"

Phrase: "and"

Phrase: "administration in Freund's complete adjuvant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "[26,"

Phrase: "27"

Phrase: "]."
Processing 00000000.tx.36: Qiao et al., in the current issue of Rheumatology, show that immunization of naive mice with genomic DNA derived from concanavalin A-stimulated syngeneic splenocytes evoked anti-dsDNA antibody production and glomerulonephritis, while genomic DNA from non-activated splenocytes failed to be an immunogen. 

Phrase: "Qiao et al.,"

Phrase: "in the current issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]

Phrase: "of Rheumatology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035452:Rheumatology [Biomedical Occupation or Discipline]
  1000   C0334889:Rheumatology [Professional or Occupational Group]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that immunization of naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C3244291:immunization [Functional Concept]

Phrase: "with genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "derived from concanavalin A-stimulated syngeneic splenocytes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0009630:Concanavalin A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           concanavalin
   748   C1441547:Derived [Qualitative Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2348628:Syngeneic [Qualitative Concept]
   748   C2924614:concanavalin [Immunologic Factor]
   748   C3245521:derived [Idea or Concept]
   714   C1519477:Splenocyte [Cell]

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "anti-dsDNA antibody production"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   869   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   842 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   833   C0919679:double stranded dna antibody [Laboratory Procedure]
   833   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   800   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   770   C0003261:Antibody Production [Biologic Function]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1262035:dna antibody [Laboratory Procedure]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0033268:production [Occupational Activity]
   744   C0205173:Double [Functional Concept]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   735   C1979882:Double strand [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "glomerulonephritis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017658:Glomerulonephritis [Disease or Syndrome]

Phrase: "while"

Phrase: "genomic DNA from non-activated splenocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an immunogen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Immunogen [Immunologic Factor]
   928 E C0872192:immunogenic [Functional Concept]
Processing 00000000.tx.37: Previously, anti-DNA monoclonal antibodies were prepared using an in vitro immunization method. 

Phrase: "Previously,"

Phrase: "anti-DNA monoclonal antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1262035:dna antibody [Laboratory Procedure]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in vitro immunization method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.38: BALB/c mouse splenocytes were immunized with HeLa cell nuclear extract; 

Phrase: "BALB/c mouse splenocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1519477:Splenocyte [Cell]
   756   C0025919:BALB/c Mouse [Mammal]

Phrase: "were"

Phrase: "immunized with HeLa cell nuclear extract"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0018873:HeLa cell [Cell]
           HeLa
   790   C1518434:Nuclear Extract [Biomedical or Dental Material]
   753   C0007634:Cell [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2828366:Extract [Substance]

Phrase: ";"
Processing 00000000.tx.39: whether this antibody had any association with lupus was not analysed [28]. 

Phrase: "whether"

Phrase: "this antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "had"

Phrase: "any association with lupus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "analysed"

Phrase: "[28"

Phrase: "]."
Processing 00000000.tx.40: DNA has unique immunological properties that may affect its immunogenicity. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "unique immunological properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "that"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its immunogenicity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0872192:immunogenic [Functional Concept]
   900 E C0003320:Immunogen [Immunologic Factor]
Processing 00000000.tx.41: Thus, depending on sequence and base methylation, DNA can be stimulatory, inhibitory or neutral with respect to mitogenic activity and cytokine induction. 

Phrase: "Thus,"

Phrase: "depending on sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]
   756   C0725813:depend [Medical Device]
   718 E C1548958:Sequential [Idea or Concept]
   718 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "base methylation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0025723:Methylation [Molecular Function]
   861   C1159269:Methylation [Molecular Function]
   789 E C0746574:methylated [Pharmacologic Substance]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "can"

Phrase: "be"

Phrase: "stimulatory, inhibitory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3463820:Inhibitory [Activity]

Phrase: "or"

Phrase: "neutral with respect to mitogenic activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "cytokine induction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.42: CD4+ T-cell DNA hypomethylation may contribute to the development of drug-induced and idiopathic human lupus. 

Phrase: "CD4+ T-cell DNA hypomethylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C2613367:DNA hypomethylation [Genetic Function]

Phrase: "may"

Phrase: "contribute to the development of drug-induced"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0458082:Drug-induced [Functional Concept]
   774   C0872152:Drug Development [Biomedical Occupation or Discipline]
   748   C0013227:Drug [Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1254351:Drug [Pharmacologic Substance]
   748   C1527148:Development [Functional Concept]
   748   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "idiopathic human lupus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0409974:Lupus [Disease or Syndrome]
Processing 00000000.tx.43: Inhibiting DNA methylation in mature CD4+ T cells caused autoreactivity specific to the major histocompatibility complex in vitro. 

Phrase: "Inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "DNA methylation in mature CD4+ T cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0376452:DNA Methylation [Molecular Function]
   778   C3536933:DNA Methylation [Molecular Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0025723:Methylation [Molecular Function]
   748   C1159269:Methylation [Molecular Function]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "autoreactivity"

Phrase: "specific to the major histocompatibility complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.44: The lupus-inducing drugs hydralazine and procainamide also inhibit T-cell DNA methylation and induce autoreactivity, and T cells from patients with active lupus had hypomethylated DNA and a similarly autoreactive T-cell subset [29]. 

Phrase: "The lupus-inducing drugs hydralazine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0020223:Hydralazine [Organic Chemical,Pharmacologic Substance]
   756 E C0699178:Apresoline [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "procainamide also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033216:Procainamide [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "T-cell DNA methylation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376452:DNA Methylation [Molecular Function]
   861   C3536933:DNA Methylation [Molecular Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0025723:Methylation [Molecular Function]
   812   C1159269:Methylation [Molecular Function]
   741 E C0746574:methylated [Pharmacologic Substance]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "autoreactivity,"

Phrase: "and"

Phrase: "T cells from patients"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with active lupus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024131:Lupus [Disease or Syndrome]
   861   C0024138:lupus [Disease or Syndrome]
   861   C0409974:Lupus [Disease or Syndrome]

Phrase: "had"

Phrase: "hypomethylated DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a similarly autoreactive T-cell subset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0080202:T-Cell Subset [Cell]
   804   C1515021:Subset [Classification]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.45: Further, the pathological significance of the autoreactivity induced by inhibiting T-cell DNA methylation had been tested by treating murine T cells in vitro with drugs that modify DNA methylation, then injecting the cells into syngeneic female mice. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the pathological significance of the autoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "induced by inhibiting T-cell DNA methylation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0039194:T-cell [Cell]
   778   C0376452:DNA Methylation [Molecular Function]
   778   C3536933:DNA Methylation [Molecular Function]
   748   C0007634:Cell [Cell]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0025723:Methylation [Molecular Function]
   748   C0205263:Induced [Functional Concept]
   748   C1159269:Methylation [Molecular Function]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3463820:Inhibiting [Activity]

Phrase: "had"

Phrase: "been"

Phrase: "tested by treating murine T cells"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0026809:Murine [Mammal]
   753   C0332293:treating [Therapeutic or Preventive Procedure]
   753   C0392366:tested [Intellectual Product]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C1522326:Treating [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro with drugs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "that"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "DNA methylation,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376452:DNA Methylation [Molecular Function]
  1000   C3536933:DNA Methylation [Molecular Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0025723:Methylation [Molecular Function]
   861   C1159269:Methylation [Molecular Function]
   789 E C0746574:methylated [Pharmacologic Substance]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "injecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "the cells into syngeneic female mice."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.46: Mice receiving CD4+ T cells demethylated by a variety of agents, including procainamide and hydralazine, developed a lupus like disease [29]. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "demethylated by a variety of agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "procainamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033216:Procainamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "hydralazine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020223:Hydralazine [Organic Chemical,Pharmacologic Substance]
   944 E C0699178:Apresoline [Organic Chemical,Pharmacologic Substance]

Phrase: "developed"

Phrase: "a lupus like disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.47: Bacterial DNA, due to its higher frequency of unmethylated CpG sequences in a particular base context (CpG motif), and synthetic CpG oligodeoxynucleotides can directly stimulate dendritic cells, macrophages and B cells in a Toll-like-receptor-9 (TLR-9)-dependent fashion [26, 27, 3034]. 

Phrase: "Bacterial DNA,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "due to its higher frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   983   C0205212:High frequency [Temporal Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "of unmethylated CpG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences in a particular base context"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   753   C0002055:base [Inorganic Chemical]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0178499:Base [Chemical Viewed Functionally]
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C1880279:Base [Biomedical or Dental Material]

Phrase: "(CpG motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "synthetic CpG oligodeoxynucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "stimulate"

Phrase: "dendritic cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "B cells in a Toll-like-receptor-9 (TLR-9)-dependent fashion"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   761   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0004561:B-Cells [Cell]
   741   C1514760:Receptor Cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "[26,"

Phrase: "27,"

Phrase: "3034"

Phrase: "]."
Processing 00000000.tx.48: In B cells, bacterial DNA and CpG oligodeoxynucleotides provide protection against spontaneous and B-cell receptor-triggered apoptosis associated with increased c-Myc, c-Jun and BclXL expression and induce polyclonal B-cell proliferation, immunoglobulin secretion and isotype switching [31, 35]. 

Phrase: "In B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "bacterial DNA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "and"

Phrase: "CpG oligodeoxynucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "protection against spontaneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "B-cell receptor-triggered apoptosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   911   C1326202:B cell apoptosis [Cell Function]
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
   717   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "associated with increased c-Myc,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "BclXL expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "polyclonal B-cell proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155008:B Cell Proliferation [Cell Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "immunoglobulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1327439:immunoglobulin secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "isotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "[31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "35"

Phrase: "]."
Processing 00000000.tx.49: Lupus-prone Palmerston North (PN) mice showed a defective response to CpG oligodeoxynucleotides, as reflected by decreased IL-12p40 and IL-6 secretion compared with controls, and higher IL-10 secretion associated with accelerated lupus pathogenesis [36]. 

Phrase: "Lupus-prone Palmerston North (PN) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a defective response to CpG oligodeoxynucleotides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "as"

Phrase: "reflected by decreased IL-12p40"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1121402:IL-12p40 [Amino Acid, Peptide, or Protein]
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0558058:reflected [Mental Process]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "IL-6 secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3156665:IL-6 secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   734   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1334122:IL6 [Gene or Genome]
   734   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "higher IL-10 secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3156669:IL-10 secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "associated with accelerated lupus pathogenesis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0024131:Lupus [Disease or Syndrome]
   760   C0024138:lupus [Disease or Syndrome]
   760   C0409974:Lupus [Disease or Syndrome]
   760   C0521110:Accelerated [Functional Concept]
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[36"

Phrase: "]."
Processing 00000000.tx.50: Recently, using lupus-prone mice models (BWF1, PN), Brummel and Lenert [37] showed that CpG oligodeoxynucleotides induced marginal-zone B-cell activation, costimulatory molecule expression and polyclonal immunoglobulin secretion. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lupus-prone mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "(BWF1,"

Phrase: "PN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709269:North [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "Brummel"

Phrase: "and"

Phrase: "Lenert"

Phrase: "[37"

Phrase: "]"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CpG oligodeoxynucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "marginal-zone B-cell activation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1155003:B-Cell Activation [Cell Function]
   884   C1332420:B-cell activation [Gene or Genome]
   840   C1326120:cell activation [Cell Function]
   804   C1879547:Activation [Activity]

Phrase: "costimulatory molecule expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "polyclonal immunoglobulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1327439:immunoglobulin secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.51: The authors suggested that, through increased IL-10 secretion, marginal-zone B cells may also modify the activity of other cell types, particularly dendritic cells and macrophages [37]. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "through increased IL-10 secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3156669:IL-10 secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "marginal-zone B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "also"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the activity of other cell types,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   803   C0459205:Type of activity [Intellectual Product]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "particularly dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "[37"

Phrase: "]."
Processing 00000000.tx.52: Antibodies binding dsDNA play an important role in the pathogenesis and activity of lupus. 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "activity of lupus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.53: Although anti-dsDNA antibodies are present in the damaged area, such as the kidney, in lupus nephritis, it is not widely accepted that they are pathogenic. 

Phrase: "Although"

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "present in the damaged area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "such as the kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "in lupus nephritis,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0024143:Lupus Nephritis [Disease or Syndrome]
   861   C0024131:Lupus [Disease or Syndrome]
   861   C0024138:lupus [Disease or Syndrome]
   861   C0027697:Nephritis [Disease or Syndrome]
   861   C0409974:Lupus [Disease or Syndrome]
   768 E C0022646:Kidney [Body Part, Organ, or Organ Component]
   768 E C0227665:kidney [Body Part, Organ, or Organ Component]
   768 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   768 E C1514845:KIDNEY [Tissue]

Phrase: "it"

Phrase: "is"

Phrase: "not widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "pathogenic."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0450254:Pathogenic [Organism]
   928 E C0030657:pathogenicity [Qualitative Concept]
   928 E C1136169:Pathogenicity [Organism Attribute]
Processing 00000000.tx.54: Anti-ds DNA deposition associated with kidney damage was shown in mice infused with the immunoglobulins [3844]. 

Phrase: "Anti-ds DNA deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0333562:Deposition [Functional Concept]
   756   C0741099:anti ds dna [Finding]
   708   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "associated with kidney damage"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0010957:Damage [Injury or Poisoning]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1883709:Damage [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "shown in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C1547282:Show [Intellectual Product]

Phrase: "infused with the immunoglobulins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   737 E C1621846:immunoglobulin [Molecular Function]

Phrase: "[3844"

Phrase: "]."
Processing 00000000.tx.55: SCID mice implanted with human hybridoma cells secreted anti-dsDNA IgG that was deposited in the kidney, causing proteinuria [38, 39]. 

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   844   C1512658:Immunodeficient Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   733   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]

Phrase: "implanted with human hybridoma cells"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   797   C0427861:Human cells [Laboratory or Test Result]
   781   C0020204:cell hybridoma [Cell]
           Hybridoma
   760   C0007634:Cells [Cell]
   760   C0021102:Implanted [Medical Device]
   760   C0086418:Human [Human]
   760   C3282337:Cells [Cell]
   726 E C0021107:implant [Therapeutic or Preventive Procedure]
   726 E C0332837:Implant [Injury or Poisoning]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1711357:Implant [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "anti-dsDNA IgG"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "was"

Phrase: "deposited in the kidney,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0333562:deposited [Functional Concept]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "[38,"

Phrase: "39"

Phrase: "]."
Processing 00000000.tx.56: Some anti-dsDNA monoclonal antibodies bound to the membranous structures of the glomerulus while others penetrated into the cells and bound to nuclei in vivo [38]. 

Phrase: "Some"

Phrase: "anti-dsDNA monoclonal antibodies"
Meta Candidates (Total=24; Excluded=5; Pruned=0; Remaining=19)
   844   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   831 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   806   C0919679:double stranded dna antibody [Laboratory Procedure]
   800   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   789   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   770   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C1262035:antibodies dna [Laboratory Procedure]
   767   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205173:Double [Functional Concept]
   744   C0746619:monoclonal [Finding]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   735   C1979882:Double strand [Qualitative Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "bound to the membranous structures of the glomerulus"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   750   C0022663:Glomerulus structure [Body Part, Organ, or Organ Component]
           Glomerulus
   744   C0025255:Membranous [Tissue]
   744   C0205287:Membranous [Qualitative Concept]
   744   C0332297:bound [Spatial Concept]
   744   C0678594:structures [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   712   C0596901:membrane structure [Cell Component]

Phrase: "while"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "penetrated into the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205321:penetrated [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "bound to nuclei"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   756   C0007610:Nucleus [Cell Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "[38"

Phrase: "]."
Processing 00000000.tx.57: Penetration of anti-dsDNA into living murine renal tubular cells in vivo indicated that cellular penetration requires the presence of DNA or the binding of antibodies to a membrane determinant precisely resembling DNA [40]. 

Phrase: "Penetration of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205321:Penetration [Functional Concept]

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "into living murine renal tubular cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   840   C0552639:Tubular cells [Cell]
   836   C0553257:Renal cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0022646:Renal [Body Part, Organ, or Organ Component]
   804   C0332208:Tubular [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   768   C0022674:Renal tubule [Body Part, Organ, or Organ Component]
   768   C1283878:Renal tubule [Body Part, Organ, or Organ Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that cellular penetration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205321:Penetration [Functional Concept]

Phrase: "requires"

Phrase: "the presence of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "the binding of antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to a membrane determinant precisely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]

Phrase: "resembling"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "]."
Processing 00000000.tx.58: An additional example is the cross-reacting anti-dsDNA/P-ribosomal protein causing cellular damage [41]. 

Phrase: "An additional example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707959:Example [Conceptual Entity]

Phrase: "is"

Phrase: "the"

Phrase: "cross-reacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828360:Cross [Conceptual Entity]

Phrase: "anti-dsDNA/P-ribosomal protein"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   818   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   790   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1622856:ribosomal protein [Genetic Function]
   762   C0012933:DNA, Ribosomal [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1441153:Ribosomal P [Immunologic Factor]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0035553:Ribosomal [Cell Component]
   742   C0205173:Double [Functional Concept]
   742   C1705764:Double [Activity]
   742   C1705765:Double [Qualitative Concept]
   729   C1979882:Double strand [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "cellular damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "[41"

Phrase: "]."
Processing 00000000.tx.59: In an additional set of experiments, when radiolabelled murine anti-DNA antibodies were injected into BALB/c mice there was renal deposition of anti-dsDNA antibodies combined with proteinuria [42]. 

Phrase: "In an additional set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "when"

Phrase: "radiolabelled murine anti-DNA antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   884   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   823   C1262035:dna antibody [Laboratory Procedure]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "injected into BALB/c mice there"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025919:Mice, BALB C [Mammal]
           BALB/C
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   719   C1720154:Inject [Functional Concept]

Phrase: "was"

Phrase: "renal deposition of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposition [Functional Concept]

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "combined with proteinuria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0033687:Proteinuria [Finding]
   790   C0205195:Combined [Qualitative Concept]
   790   C1962972:Proteinuria [Finding]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "[42"

Phrase: "]."
Processing 00000000.tx.60: A synthetic peptide with the consensus sequence DWEYS, identified by a peptide phage display library, protected the kidneys from renal deposition of the anti-dsDNA in both BALB/c and SCID mice injected with anti-dsDNA [42, 43]. 

Phrase: "A synthetic peptide with the consensus sequence DWEYS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   767   C0920679:peptide sequence [Amino Acid Sequence]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1883254:synthetic [Activity]

Phrase: "identified by a peptide phage display library,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0751719:Phage Display Library, Peptide [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   778   C1519025:Phage Display [Molecular Biology Research Technique]
   774   C0376436:Peptide Library [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0004651:Phage [Virus]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205396:Identified [Qualitative Concept]
   748   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1705417:Display [Manufactured Object]

Phrase: "protected"

Phrase: "the kidneys from renal deposition of the"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   748   C0227665:kidneys [Body Part, Organ, or Organ Component]
   714 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   714 E C1514845:KIDNEY [Tissue]

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in both BALB/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "and"

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   844   C1512658:Immunodeficient Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   733   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]

Phrase: "injected with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1720154:Inject [Functional Concept]

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[42,"

Phrase: "43"

Phrase: "]."
Processing 00000000.tx.61: This peptide binds the anti-dsDNA antibodies in or near the dsDNA binding site [43]. 

Phrase: "This peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the"

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in"

Phrase: "or near the dsDNA binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   790   C1148741:dsDNA binding [Genetic Function]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "[43"

Phrase: "]."
Processing 00000000.tx.62: Immunization of naive mice with DWEYS DNA mimetic in a branched form induced the generation of mouse anti-dsDNA associated with renal damage [44]. 

Phrase: "Immunization of naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "with DWEYS DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mimetic in a branched form"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0920591:mimetic [Biomedical Occupation or Discipline]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the generation of mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "anti-dsDNA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "associated with renal damage"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0010957:Damage [Injury or Poisoning]
   770   C0022646:Renal [Body Part, Organ, or Organ Component]
   770   C1883709:Damage [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[44"

Phrase: "]."
Processing 00000000.tx.63: It has been suggested that cross-reactivity of anti-DNA antibodies plays a central role in the development of lupus nephritis. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cross-reactivity of anti-DNA antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0010357:Cross Reactivity [Molecular Function]
   778   C0872139:cross reactivity [Molecular Function]
   778   C1880190:CROSS REACTIVITY [Event]
   748   C2828360:Cross [Conceptual Entity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in the development of lupus nephritis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.64: A case of molecular mimicry between cross-reacting anti-dsDNA antibodies with the glomerular protein -actinin was identified by mass spectroscopy [45]. 

Phrase: "A case of molecular mimicry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "between"

Phrase: "cross-reacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828360:Cross [Conceptual Entity]

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with the glomerular protein -actinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001245:Actinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "identified by mass spectroscopy"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0037813:Spectroscopy, Mass [Laboratory Procedure]
   770   C0037812:spectroscopy [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2713504:Spectroscopy [Occupation or Discipline]
   770   C2984732:SPECTROSCOPY [Functional Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "[45"

Phrase: "]."
Processing 00000000.tx.65: -Actinin is an actin-binding protein and is a major structural component of glomerular podocytes and mesangial cells, and is known to play a prominent role in several experimental glomerulonephritis models. 

Phrase: "-Actinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001245:Actinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an actin-binding protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0001239:Actin-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1149245:actin binding [Molecular Function]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a major structural component of glomerular podocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "mesangial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a prominent role in several experimental glomerulonephritis models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0178835:models role [Population Group]
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.66: The anti--actinin antibodies were colocalized with in vivo-deposited anti-DNA monoclonal antibodies in the RAG-1-deficient mouse and were deposited in the mesangium of BWF1 kidneys [45]. 

Phrase: "The anti"

Phrase: "--"

Phrase: "actinin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "colocalized with in vivo-deposited anti-DNA monoclonal antibodies"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   784   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   764   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C1515655:In Vivo [Spatial Concept]
           vivo
   762   C1262035:antibodies dna [Laboratory Procedure]
   762   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   745 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0333562:deposited [Functional Concept]
   742   C0746619:monoclonal [Finding]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the RAG-1-deficient mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "were"

Phrase: "deposited in the mesangium of BWF1 kidneys"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0017655:Mesangium [Body Part, Organ, or Organ Component]
   748   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   748   C0227665:kidneys [Body Part, Organ, or Organ Component]
   748   C0333562:deposited [Functional Concept]
   714 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   714 E C1514845:KIDNEY [Tissue]

Phrase: "[45"

Phrase: "]."
Processing 00000000.tx.67: In the lupus-prone MRL-lpr/lpr mouse and in a non-autoimmune BALB/c mouse subjected to the pathogenic anti-DNA antibody R4A, anti--actinin was eluted from the affected kidneys [46]. 

Phrase: "In the lupus-prone MRL-lpr/lpr mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0376632:Mouse, MRL lpr [Mammal]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "and in a non-autoimmune BALB/c mouse"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0025919:BALB/c Mouse [Mammal]
           BALB/C
   767   C1513853:NON Mouse [Mammal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0443146:Autoimmune [Pathologic Function]
   744   C1515981:And [Idea or Concept]
   744   C1518422:Non [Functional Concept]

Phrase: "subjected to the pathogenic anti-DNA antibody R4A,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   770   C1262035:dna antibody [Laboratory Procedure]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0450254:Pathogenic [Organism]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "anti"

Phrase: "--"

Phrase: "actinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001245:Actinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted from the affected kidneys"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   760   C0227665:kidneys [Body Part, Organ, or Organ Component]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   726 E C1514845:KIDNEY [Tissue]

Phrase: "[46"

Phrase: "]."
Processing 00000000.tx.68: The consensus sequence Asp/Glu-Trp-As/Glu-Tyr-Ser/Gly (a molecular mimic of dsDNA), was observed also in subunits of the glutamate receptors NR2a and NR2b [47]. 

Phrase: "The consensus sequence Asp/Glu-Trp-As/Glu-Tyr-Ser/Gly ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   868   C0052546:Asp-Gly [Amino Acid, Peptide, or Protein]
   846   C0077449:Trp-Gly [Amino Acid, Peptide, or Protein]
   790   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "a molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "mimic of dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "also in subunits of the glutamate receptors NR2a"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   744   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   744   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C1415299:NR2A [Gene or Genome]
   744   C3273845:NR2A [Gene or Genome]
   744   C3273846:NR2A [Amino Acid, Peptide, or Protein]
   711   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "NR2b"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415300:NR2B [Gene or Genome]
  1000   C3537346:NR2B [Amino Acid, Peptide, or Protein]
  1000   C3538769:NR2B [Gene or Genome]

Phrase: "[47"

Phrase: "]."
Processing 00000000.tx.69: Anti-dsDNA antibodies binding the peptide, injected intrathecally into naive mice, could mediate excitotoxic neuronal death [47]. 

Phrase: "Anti-dsDNA antibodies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0236300:Anti-ds-DNA Antibodies [Laboratory Procedure]
   988 E C2355607:Anti dsDNA antibody [Finding]
   988 E C2746079:Anti-dsDNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0741099:anti ds dna [Finding]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intrathecally into naive mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "could"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "excitotoxic neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C2754100:neuron death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "[47"

Phrase: "]."
Processing 00000000.tx.70: Anti-DNA activity can be evoked indirectly by idiotypic manipulation using anti-DNA antibodies [4858] or by lymphocyte transfer [5961]. 

Phrase: "Anti-DNA activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "can"

Phrase: "be"

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "indirectly by idiotypic manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
   770   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-DNA antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1262035:dna antibody [Laboratory Procedure]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "[4858"

Phrase: "]"

Phrase: "or by lymphocyte transfer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024264:Lymphocyte [Cell]
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "[5961"

Phrase: "]."
Processing 00000000.tx.71: Based on Jerne idiotype network theory, immunization with a human anti-dsDNA antibody (Ab1) will evoke anti-idiotypic antibody (Ab2) and later anti-anti-dsDNA antibody (Ab3), which resembles the immunizing Ab1, namely mouse anti-dsDNA antibodies [4850]. 

Phrase: "Based on Jerne idiotype network theory,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0871935:Theory [Idea or Concept]
   753   C1513822:Network [Professional or Occupational Group]
   753   C1527178:Based [Functional Concept]
   753   C1705739:Network [Manufactured Object]
   753   C1705938:Based [Idea or Concept]
   753   C1882071:Network [Conceptual Entity]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "immunization with a human"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "anti-dsDNA antibody"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   897   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C0919679:double stranded dna antibody [Laboratory Procedure]
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1262035:dna antibody [Laboratory Procedure]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Ab1"

Phrase: ")"

Phrase: "will"

Phrase: "evoke"

Phrase: "anti-idiotypic antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003242:Antibody, Anti-Idiotypic [Amino Acid, Peptide, or Protein,Immunologic Factor]
           anti antibody
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ab2"

Phrase: ")"

Phrase: "and"

Phrase: "later anti-"

Phrase: "anti-dsDNA antibody"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   897   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C0919679:double stranded dna antibody [Laboratory Procedure]
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1262035:dna antibody [Laboratory Procedure]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Ab3"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "resembles"

Phrase: "the immunizing Ab1,"

Phrase: "namely mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[4850"

Phrase: "]."
Processing 00000000.tx.72: Immunization of naive mice with anti-DNA carrying the 16/6 idiotype induced experimental lupus manifesting as leucopenia, increased sedimentation rate, glomerulonephritis and proteinuria [51]. 

Phrase: "Immunization of naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "with anti-DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the 16/6 idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "experimental lupus manifesting as leucopenia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205319:manifesting [Functional Concept]

Phrase: "increased sedimentation rate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0151632:increased sedimentation rate [Finding]
   901   C1176468:Sedimentation rate, NOS [Laboratory Procedure]
   827   C0597428:Sedimentation [Laboratory Procedure]
   827   C0871208:Rate [Activity]
   827   C1384604:Sedimentation [Natural Phenomenon or Process]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "glomerulonephritis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017658:Glomerulonephritis [Disease or Syndrome]

Phrase: "and"

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "[51"

Phrase: "]."
Processing 00000000.tx.73: A peptide based on the complementarity-determining region (CDR)1 of a monoclonal murine anti-DNA antibody that bears the common idiotype 16/6Id was synthesized and used to treat 16/6-induced lupus mice [52]. 

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "based on the complementarity-determining region (CDR)1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   853   C0887926:Complementarity Determining Region 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   814   C0021024:Complementarity-Determining Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "of a monoclonal murine anti-DNA antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1262035:dna antibody [Laboratory Procedure]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "the common idiotype 16/6Id"

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "16/6-induced lupus mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "[52"

Phrase: "]."
Processing 00000000.tx.74: Amelioration of the clinical manifestations of an established experimental lupus correlated with a decrease in TNF- secretion, elevated levels of TGF-, and immunomodulation of the Th1- and Th2-type cytokines to levels close to those observed in healthy mice [52]. 

Phrase: "Amelioration of the clinical manifestations of an established experimental lupus"

Phrase: "correlated with a decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in TNF- secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "elevated levels of TGF-,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "immunomodulation of the Th1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678889:Immunomodulation [Organism Function]
   770   C1963758:Immunomodulation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Th2-type cytokines to levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "close to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "observed in healthy mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1441672:Observed [Functional Concept]

Phrase: "[52"

Phrase: "]."
Processing 00000000.tx.75: This peptide is currently at the stage of clinical trials. 

Phrase: "This peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "currently at the stage of clinical trials."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0008976:Clinical Trials [Research Activity]
           Trial
   778   C1096775:clinical trials [Intellectual Product]
   774   C0205563:Clinical stage [Temporal Concept]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0205390:Stage [Temporal Concept]
   748   C0521116:Currently [Temporal Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.76: Other groups were able to repeat this successfully using polyclonal and monoclonal anti-DNA antibodies in mice and rabbits [5356]. 

Phrase: "Other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "this successfully"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal"

Phrase: "and"

Phrase: "monoclonal anti-DNA antibodies in mice"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   792   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   783   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1262035:antibodies dna [Laboratory Procedure]
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "[5356"

Phrase: "]."
Processing 00000000.tx.77: Others failed and explained the differences as a dependency on environmental factors [57]. 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "and"

Phrase: "explained"

Phrase: "the differences as a dependency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "on environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "[57"

Phrase: "]."
Processing 00000000.tx.78: Splenocytes from BWF1 mice, passively transferred to SCID, mice evoked anti-dsDNA generation combined with glomerulonephritis [59]. 

Phrase: "Splenocytes from BWF1 mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1519477:Splenocyte [Cell]

Phrase: "passively"

Phrase: "transferred to SCID, mice"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   882   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   809   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]
   773   C1512658:Immunodeficient Mouse [Mammal]
   754   C0494261:Combined immunodeficiencies [Disease or Syndrome]
   753   C0021051:Immunodeficient [Disease or Syndrome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205082:Severe [Qualitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   753   C0348011:transferred [Functional Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1705822:Transfer [Activity]

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "anti-dsDNA generation"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0079411:Generation [Temporal Concept]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   748   C3146294:Generation [Activity]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "combined with glomerulonephritis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017658:Glomerulonephritis [Disease or Syndrome]
   790   C0205195:Combined [Qualitative Concept]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "[59"

Phrase: "]."
Processing 00000000.tx.79: SCID mice were engrafted either with peripheral blood lymphocytes (PBL) of patients with SLE, or lethally irradiated BALB/c mice radioprotected with bone marrow of SCID mice, to which human PBL were transferred (human/mouse chimera) [60]. 

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   844   C1512658:Immunodeficient Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   733   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]

Phrase: "were"

Phrase: "engrafted"

Phrase: "either with peripheral blood lymphocytes (PBL) of patients"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   780   C1518997:Peripheral Blood Lymphocyte [Cell]
   778   C0229664:peripheral blood [Body Substance]
           Blood
   762   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205100:Peripheral [Spatial Concept]
   737 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]

Phrase: "with SLE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]

Phrase: "or"

Phrase: "lethally irradiated BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0025919:Mice, BALB C [Mammal]
           BALB/C
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "radioprotected with bone marrow of SCID mice,"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   818   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   767   C1511243:Mouse Bone Marrow [Tissue]
   766   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]
   764   C0005953:Bone Marrow [Tissue]
   748   C1512658:Immunodeficient Mouse [Mammal]
   745   C1511240:Mouse Bone [Tissue]
   742   C0021051:Immunodeficient [Disease or Syndrome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0086590:Marrow [Food]
   742   C0205082:Severe [Qualitative Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   742   C0376152:Marrow [Body Part, Organ, or Organ Component]
   742   C0391978:Bone [Tissue]
   742   C1266908:Bone [Body Part, Organ, or Organ Component]
   742   C1266909:Bone [Body System]
   742   C1546708:Marrow [Intellectual Product]
   734 E C1708973:Medullary Bone [Tissue]
   729   C0494261:Combined immunodeficiencies [Disease or Syndrome]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "to which human PBL"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   890   C1518997:Peripheral Blood Lymphocyte [Cell]
   861   C0229664:peripheral blood [Body Substance]
           Blood
   844   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0205100:Peripheral [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "(human/mouse chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: ")"

Phrase: "[60"

Phrase: "]."
Processing 00000000.tx.80: The engrafted mice developed anti-dsDNA, proteinuria, human IgG complex deposits as well as deposits of murine complement C3. 

Phrase: "The engrafted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "anti-dsDNA,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   833   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "proteinuria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "human IgG complex deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C2959643:IgG deposit [Finding]
   812   C0333562:Deposits [Functional Concept]

Phrase: "as well as"

Phrase: "deposits of murine complement C3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0009506:Complement C3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0333586:Complement deposit [Pathologic Function]
   760   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0026809:Murine [Mammal]
   760   C0333562:Deposit [Functional Concept]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.81: Treatment with a synthetic peptide derived from the anti-DNA 16/6 CDR1 resulted in significant amelioration of the clinical features of SLE [61]. 

Phrase: "Treatment with a synthetic peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "derived from the anti-DNA 16/6 CDR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1441547:Derived [Qualitative Concept]
   744   C3245521:derived [Idea or Concept]

Phrase: "resulted in significant amelioration of the clinical features of SLE"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   770   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   770   C2984317:Systemic lupus erythematosus [Functional Concept]
   753   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   736   C0024131:Lupus [Disease or Syndrome]
   736   C0024138:lupus [Disease or Syndrome]
   736   C0205210:Clinical [Qualitative Concept]
   736   C0205373:Systemic [Functional Concept]
   736   C0237881:significant [Quantitative Concept]
   736   C0750502:Significant [Idea or Concept]
   736   C1546944:Significant [Qualitative Concept]
   715   C2826293:Clinical Significance [Finding]
   703   C1274040:Result [Functional Concept]
   703   C1521970:Feature [Qualitative Concept]
   703   C1546471:Result [Idea or Concept]
   703   C1706388:Feature [Conceptual Entity]
   703   C2346469:Feature [Qualitative Concept]
   703   C2348519:Feature [Qualitative Concept]
   703   C2825142:Result [Finding]

Phrase: "[61"

Phrase: "]."
Processing 00000000.tx.82: Data from experimental models point to the possibility of diverse origins for anti-dsDNA antibodies. 

Phrase: "Data from experimental models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "point to the possibility of diverse origins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0079946:origins [Classification]
   748   C0439659:Origins [Temporal Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C1880371:Diverse [Qualitative Concept]
   748   C2347617:point [Quantitative Concept]
   714 E C1550512:origin [Intellectual Product]
   702   C0042333:Genetic Diversities [Natural Phenomenon or Process]

Phrase: "for"

Phrase: "anti-dsDNA antibodies."
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.83: In addition to an increased number of circulating apoptotic cells and impaired clearance, the possible infectious origin was documented [62, 63]. 

Phrase: "In addition to an increased number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of circulating apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "impaired clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "the possible infectious origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: "was"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "[62,"

Phrase: "63"

Phrase: "]."
Processing 00000000.tx.84: Cross-reactive antibodies to dsDNA and phosphatidylcholine were raised in mice upon lethal pneumococcal infection and were found to be protective in naive mice on the one hand and to display pathogenic autoreactivity on the other hand [62]. 

Phrase: "Cross-reactive antibodies to dsDNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0010357:Cross-reactive [Molecular Function]
   797   C0312612:antibodies dsdna [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205332:Reactive [Qualitative Concept]
   760   C2828360:Cross [Conceptual Entity]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphatidylcholine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "raised in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0442818:Raised [Quantitative Concept]

Phrase: "upon lethal pneumococcal infection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0032269:Pneumococcal infection [Disease or Syndrome]
   827   C0009450:Infection, NOS [Disease or Syndrome]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "protective in naive mice"

Phrase: "on the one hand"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "pathogenic autoreactivity on the"

Phrase: "other hand [62"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "]."
Processing 00000000.tx.85: Genetic susceptibility to the effects of B-cell infection with EpsteinBarr virus leads to an increased number of latently infected autoreactive memory B cells, which lodge in organs where their target antigen is expressed, and act there as antigen-presenting cells [63, 64]. 

Phrase: "Genetic susceptibility to the effects of B-cell infection"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   784   C0521978:Susceptibility to infection [Clinical Attribute]
   764   C0314657:Genetic Susceptibility [Organism Attribute]
   756   C0205624:B-cell origin [Qualitative Concept]
   742   C0012655:Susceptibility [Clinical Attribute]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0220898:Susceptibility [Organism Attribute]
   742   C0314603:Genetic [Functional Concept]
   742   C1264642:Susceptibility [Functional Concept]
   742   C1547045:*Susceptibility [Quantitative Concept]
   720   C0729552:Genital infection [Disease or Syndrome]

Phrase: "with EpsteinBarr virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "leads to an increased number of latently"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0861064:increased lead [Finding]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0205217:Increased [Quantitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "autoreactive memory B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   906   C0682638:Memory B Cell [Cell]
   875   C0312737:Memory cells [Cell]
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "lodge in organs where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "their target antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "is"

Phrase: "expressed"

Phrase: ","

Phrase: "and"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "there"

Phrase: "as"

Phrase: "antigen-presenting cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "[63,"

Phrase: "64"

Phrase: "]."
Processing 00000000.tx.86: When CD4+ T cells that recognize antigens within the target organ are activated in lymphoid organs by cross-reactivity with infectious agents, they migrate to the target organ but fail to undergo activation-induced apoptosis because they receive a costimulatory survival signal from the infected B cells. 

Phrase: "When"

Phrase: "CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "recognize"

Phrase: "antigens within the target organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003320:Antigens [Immunologic Factor]

Phrase: "are"

Phrase: "activated in lymphoid organs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0502330:lymphoid organs [Body Part, Organ, or Organ Component]
   816 E C1283883:Lymphoid organ [Body Part, Organ, or Organ Component]
   770   C0178784:organs [Body Part, Organ, or Organ Component]
   770   C1518071:Lymphoid [Qualitative Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "by cross-reactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]
   861   C2828360:Cross [Conceptual Entity]
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "with infectious agents,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0314732:Infectious Agents [Organism]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
   789   C0009450:Infection, NOS [Disease or Syndrome]
   768 E C0030657:infectivity [Qualitative Concept]
   761 E C0439663:Infected [Functional Concept]

Phrase: "they"

Phrase: "migrate to the target organ"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0178784:Organ [Body Part, Organ, or Organ Component]
   760   C0232902:migrate [Functional Concept]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "but"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "activation-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "a costimulatory survival signal from the infected B cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0037083:signal cell [Cell Function]
   742   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.87: The autoreactive T cells proliferate and produce cytokines, which recruit other inflammatory cells, with resultant target organ damage and chronic autoimmune disease [63, 64]. 

Phrase: "The autoreactive T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "proliferate"

Phrase: "and"

Phrase: "produce"

Phrase: "cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "recruit"

Phrase: "other inflammatory cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0440752:inflammatory cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0333348:Inflammatory [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with resultant target organ damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0010957:Damage [Injury or Poisoning]
   812   C0178784:Organ [Body Part, Organ, or Organ Component]
   812   C1521840:Target [Functional Concept]
   812   C1883709:Damage [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "chronic autoimmune disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0008679:Chronic disease [Disease or Syndrome]
   901   C0004364:Autoimmune Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0443146:Autoimmune [Pathologic Function]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "[63,"

Phrase: "64"

Phrase: "]."
Processing 00000000.tx.88: Thus, these infected B cells might be a source of long-lived B cells in lupus. 

Phrase: "Thus,"

Phrase: "these infected B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a source of long-lived B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]

Phrase: "in lupus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024131:Lupus [Disease or Syndrome]
  1000   C0024138:lupus [Disease or Syndrome]
  1000   C0409974:Lupus [Disease or Syndrome]
Processing 00000000.tx.89: Double-transgenic BALB/c mice expressing both the R4A-2b heavy chain and the anti-apoptotic bcl-2 gene in the B-cell compartment were used to study whether bcl-2 overexpression differentially affects the anergic and deleted B cells. 

Phrase: "Double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic BALB/c mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0025919:Mice, BALB C [Mammal]
           BALB/C
   902   C0025936:Mice, Transgenic [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "both the R4A-2b heavy chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420192:heavy chain [Gene or Genome]
   812   C0337112:Chain [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "the anti-apoptotic bcl-2 gene in the B-cell compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   775   C0376515:bcl-2 Gene [Gene or Genome]
   775   C1704467:BCL-2 Gene [Gene or Genome]
   754   C1861886:CELL Gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "whether"

Phrase: "bcl-2 overexpression differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the anergic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0206120:Anergy [Cell Function]

Phrase: "and"

Phrase: "deleted B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.90: The double-transgenic mice (R4A/bcl-2) expressed elevated serum titres of both high- and low-affinity anti-dsDNA antibodies and displayed rescue of autoreactive B cells, which are normally either deleted or anergized. 

Phrase: "The double-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(R4A/bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0376515:Bcl-2 [Gene or Genome]

Phrase: ")"

Phrase: "expressed"

Phrase: "elevated serum titres of both high-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0475208:Titre [Quantitative Concept]

Phrase: "and"

Phrase: "low-affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C1550472:low [Idea or Concept]

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "displayed rescue of autoreactive B cells,"

Phrase: "which"

Phrase: "are"

Phrase: "normally either"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "or"

Phrase: "anergized."
Processing 00000000.tx.91: Despite the presence of anti-dsDNA antibodies in their serum, R4A/bcl-2-transgenic mice did not develop nephritis, demonstrating that overexpression of bcl-2 is not by itself sufficient to allow disease progression [65]. 

Phrase: "Despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of"

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in their serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "R4A/bcl-2-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "nephritis,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0027697:Nephritis [Disease or Syndrome]
   907 E C0022646:Kidney [Body Part, Organ, or Organ Component]
   907 E C0227665:kidney [Body Part, Organ, or Organ Component]
   907 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   907 E C1514845:KIDNEY [Tissue]

Phrase: "demonstrating"

Phrase: "that overexpression of bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "not by itself sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205410:Sufficient [Qualitative Concept]
   760   C1518422:Not [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "disease progression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242656:Disease Progression [Pathologic Function]
           progression
  1000   C1947900:Disease progression NOS [Finding]
   861   C0449258:Progression [Functional Concept]

Phrase: "[65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.92: Analysis of the lifespan of anti-dsDNA-secreting cells in the spleens of BWF1 mice showed that fewer than 60% of the splenic autoantibody-secreting cells were short-lived plasmablasts, whereas 40% were non-dividing, long-lived plasma cells with a half-life of >6 months. 

Phrase: "Analysis of the lifespan of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "anti-dsDNA-secreting cells"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   833   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   800   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750   C0699040:cell associated [Cell Component]
   744   C0007634:Cells [Cell]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205173:Double [Functional Concept]
   744   C1327616:Secreting [Cell Function]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   744   C3282337:Cells [Cell]
   735   C1979882:Double strand [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "in the spleens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037993:Spleens [Body Part, Organ, or Organ Component]
   966 E C0771377:SPLEEN [Tissue]
   966 E C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "of BWF1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that fewer than 60% of the splenic autoantibody-secreting cells"

Phrase: "were"

Phrase: "short-lived plasmablasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0229657:Plasmablast [Cell]
   793   C2698870:Plasmablast [Laboratory Procedure]

Phrase: "whereas"

Phrase: "40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "were"

Phrase: "non-dividing, long-lived plasma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   893   C1512899:Non-dividing Cell [Cell]
   859   C0230517:Dividing cell [Cell]
   827   C0032112:Plasma Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0032105:Plasma [Body Substance]
   799   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "with a half-life of >6 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439231:months [Temporal Concept]
   771 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.93: In NZB/W mice and D42 Ig heavy chain knock-in mice, a fraction of DNA-specific plasma cells were also long-lived. 

Phrase: "In NZB/W mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025926:Mice, NZB [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "D42 Ig heavy chain knock-in mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C1517676:Knock-in [Research Activity]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "a fraction of DNA-specific plasma cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   757   C0805525:Cell Fraction [Cell Component]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "also long-lived."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]
   793   C1548795:Live [Qualitative Concept]
   793   C1634625:% live [Qualitative Concept]
   793   C2982691:Live [Activity]
Processing 00000000.tx.94: Although antiproliferative immunosuppressive therapy depleted short-lived plasmablasts, long-lived plasma cells survived and continued to produce autoantibodies. 

Phrase: "Although"

Phrase: "antiproliferative immunosuppressive therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021079:Immunosuppressive therapy [Therapeutic or Preventive Procedure]
   827   C0021081:immunosuppressive [Immunologic Factor,Pharmacologic Substance]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "short-lived plasmablasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0229657:Plasmablast [Cell]
   793   C2698870:Plasmablast [Laboratory Procedure]

Phrase: "long-lived plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0032112:Plasma Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0032105:Plasma [Body Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "survived"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "and"

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "autoantibodies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.95: Thus, long-lived, autoreactive plasma cells are a relevant target for researchers aiming to develop curative therapies for autoimmune diseases [66]. 

Phrase: "Thus,"

Phrase: "long-lived,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205166:Long [Qualitative Concept]
   861   C1706317:Long [Qualitative Concept]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2982691:Live [Activity]

Phrase: "autoreactive plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0032112:Plasma Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "a relevant target for researchers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "aiming"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "curative therapies for autoimmune diseases"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0087111:therapies [Therapeutic or Preventive Procedure]
   726 E C0039798:therapy [Functional Concept]
   726 E C1363945:Therapy [Finding]

Phrase: "[66"

Phrase: "]."
Processing 00000000.tx.96: Lupus experimental models, such as the one presented in this issue by Qiao et al., contribute to our understanding of the mechanisms of pathogenicity in this disease. 

Phrase: "Lupus experimental models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0086272:Models, Experimental [Intellectual Product]
   827   C3161035:Models [Intellectual Product]

Phrase: "such as the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "presented in this issue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0033213:Issue [Finding]
   770   C0449450:Presented [Idea or Concept]
   770   C1706387:Issue [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "by Qiao et al.,"

Phrase: "contribute to our understanding of the mechanisms of pathogenicity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0030657:pathogenicity [Qualitative Concept]
   742   C0162340:Understanding [Mental Process]
   742   C0441712:Mechanisms [Functional Concept]
   742   C1136169:Pathogenicity [Organism Attribute]
   742   C1880177:Contribute [Activity]
   708 E C1706376:Mechanism [Manufactured Object]

Phrase: "in this disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.97: This knowledge is essential for developing new therapeutic modalities for treating lupus patients, a disease with no breakthrough treatment until now. 

Phrase: "This knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "is"

Phrase: "essential for developing new therapeutic modalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "for treating lupus patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "a disease with no breakthrough treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "until"

Phrase: "now."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]
Processing 00000000.tx.98: References Berden JH. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Berden JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.99: Lupus nephritis. 

Phrase: "Lupus nephritis."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0024143:Lupus Nephritis [Disease or Syndrome]
   861   C0024131:Lupus [Disease or Syndrome]
   861   C0024138:lupus [Disease or Syndrome]
   861   C0027697:Nephritis [Disease or Syndrome]
   861   C0409974:Lupus [Disease or Syndrome]
   768 E C0022646:Kidney [Body Part, Organ, or Organ Component]
   768 E C0227665:kidney [Body Part, Organ, or Organ Component]
   768 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   768 E C1514845:KIDNEY [Tissue]
Processing 00000000.tx.100: Kidney Int 1997;52:53858.[ISI][Medline] Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. 

Phrase: "Kidney Int 1997"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";52"

Phrase: ":"

Phrase: "53858."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherer Y,"

Phrase: "Gorstein A,"

Phrase: "Fritzler MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Shoenfeld Y."
Processing 00000000.tx.101: Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. 

Phrase: "Autoantibody explosion in systemic lupus erythematosus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005700:explosion [Injury or Poisoning]
   753   C0015329:Explosion [Phenomenon or Process]

Phrase: ":"

Phrase: "more than 100 different antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205172:More [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "found in SLE patients."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   833   C2984317:Systemic lupus erythematosus [Functional Concept]
   790   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   753   C0024131:Lupus [Disease or Syndrome]
   753   C0024138:lupus [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0150312:Found [Quantitative Concept]
   753   C0205373:Systemic [Functional Concept]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.102: Semin Arthritis Rheum 2004;34:50137.[CrossRef][ISI][Medline] Rekvig OP, Nossent JC. 

Phrase: "Semin Arthritis Rheum 2004"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0003864:Arthritis [Disease or Syndrome]
   812   C0035431:Rheum [Plant]
   719 E C0018099:Gout [Disease or Syndrome]

Phrase: ";34"

Phrase: ":"

Phrase: "50137."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rekvig OP,"

Phrase: "Nossent JC."
Processing 00000000.tx.103: Anti-dsDNAantibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? 

Phrase: "Anti-dsDNAantibodies,"

Phrase: "nucleosomes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028623:Nucleosomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1166675:nucleosome [Cell Component]

Phrase: "and"

Phrase: "systemic lupus erythematosus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]

Phrase: ":"

Phrase: "a time for new paradigms?"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.104: Arthritis Rheum 2003;48:30012.[CrossRef][ISI][Medline] Mohan C, Adams S, Stanik V, Datta SK. 

Phrase: "Arthritis Rheum 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";48"

Phrase: ":"

Phrase: "30012."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mohan C,"

Phrase: "Adams S,"

Phrase: "Stanik V,"

Phrase: "Datta SK."
Processing 00000000.tx.105: Nucleosome: a major immunogen for the pathogenic autoantibody-inducing T cells of lupus. 

Phrase: "Nucleosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028623:Nucleosome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166675:nucleosome [Cell Component]

Phrase: ":"

Phrase: "a major immunogen for the pathogenic autoantibody-inducing T cells of lupus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0003320:Immunogen [Immunologic Factor]
Processing 00000000.tx.106: J Exp Med 1993;177:136781.[Abstract/Free FullText] Kaliyaperumal A, Michaels MA, Datta SK. 

Phrase: "J Exp Med 1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";177"

Phrase: ":"

Phrase: "136781."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaliyaperumal A,"

Phrase: "Michaels MA,"

Phrase: "Datta SK."
Processing 00000000.tx.107: Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. 

Phrase: "Antigen-specific therapy of murine lupus nephritis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0039798:therapy [Functional Concept]
   748   C0087111:Therapy [Therapeutic or Preventive Procedure]
   748   C1363945:Therapy [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nucleosomal peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "tolerance"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0013220:Tolerance [Finding]
  1000   C0020963:Tolerance [Pathologic Function]
  1000   C0220929:tolerance [Mental Process]
  1000   C0231197:Tolerance [Physiologic Function]
  1000   C1704410:Tolerance [Qualitative Concept]
   944 E C0680282:toleration [Social Behavior]
   928 E C0231198:Tolerant [Functional Concept]

Phrase: "spreading"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332261:Spreading [Qualitative Concept]
   966 E C1947932:Spread [Activity]

Phrase: "impairs"

Phrase: "pathogenic function of autoimmune T"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.108: J Immunol 1999;162:577583.[Abstract/Free FullText] Casiola-Rosen LA, Anhalt G, Rosen A. 

Phrase: "J Immunol 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";162"

Phrase: ":"

Phrase: "577583."

Phrase: "[Abstract/Free FullText"

Phrase: "] Casiola-Rosen LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023031:La [Element, Ion, or Isotope]

Phrase: "Anhalt G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rosen A."
Processing 00000000.tx.109: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. 

Phrase: "Autoantigens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004359:Autoantigens [Immunologic Factor]

Phrase: "targeted in systemic lupus erythematosus"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   862   C2984317:Systemic lupus erythematosus [Functional Concept]
   806   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   760   C0024131:Lupus [Disease or Syndrome]
   760   C0024138:lupus [Disease or Syndrome]
   760   C0205373:Systemic [Functional Concept]
   760   C1521840:Targeted [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "are"

Phrase: "clustered in two populations of surface structures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0032659:Population [Quantitative Concept]
   748   C0205148:Surface [Spatial Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1257890:Population [Population Group]
   714   C1555715:Cluster [Idea or Concept]
   714   C1704332:Cluster [Quantitative Concept]

Phrase: "on apoptotic keratinocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022567:Keratinocytes [Cell]
Processing 00000000.tx.110: J Exp Med 1994;179:131730.[Abstract/Free FullText] Utz PJ, Hottelet M, Schur PH, Anderson P. 

Phrase: "J Exp Med 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";179"

Phrase: ":"

Phrase: "131730."

Phrase: "[Abstract/Free FullText"

Phrase: "] Utz PJ,"

Phrase: "Hottelet M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schur PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Anderson P."
Processing 00000000.tx.111: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phosphorylated during stress-induced apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038435:Stress [Finding]
   760   C0162638:Apoptosis [Cell Function]
   760   C0205263:Induced [Functional Concept]

Phrase: "are"

Phrase: "common targets for autoantibody production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.112: J Exp Med 1997;185:84354.[Abstract/Free FullText] Utz PJ, Anderson P. 

Phrase: "J Exp Med 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";185"

Phrase: ":"

Phrase: "84354."

Phrase: "[Abstract/Free FullText"

Phrase: "] Utz PJ,"

Phrase: "Anderson P."
Processing 00000000.tx.113: Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. 

Phrase: "Posttranslational protein modifications,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0033666:Protein Modifications, Post-Translational [Molecular Function]
           Post-Translational Modifications
           Protein Modification
   884   C2263112:protein modification [Molecular Function]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "the bypass of tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0741847:Bypass [Therapeutic or Preventive Procedure]

Phrase: "to autoantigens."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004359:Autoantigens [Immunologic Factor]
Processing 00000000.tx.114: Arthritis Rheum 1998;41:115260.[CrossRef][ISI][Medline] Bijl M, Limburg PC, Kallenberg CGM. 

Phrase: "Arthritis Rheum 1998"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";41"

Phrase: ":"

Phrase: "115260."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bijl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Limburg PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Kallenberg CGM."
Processing 00000000.tx.115: New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. 

Phrase: "New insights into the pathogenesis of systemic lupus erythematosus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:insights [Mental Process]

Phrase: "(SLE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ":"

Phrase: "the role of apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.116: Neth J Med 2001;59:6675.[CrossRef][ISI][Medline] Mevorach D, Zhou JL, Song X, Elkon KB. 

Phrase: "Neth J Med 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0265962:NETH [Congenital Abnormality,Disease or Syndrome]

Phrase: ";59"

Phrase: ":"

Phrase: "6675."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mevorach D,"

Phrase: "Zhou JL,"

Phrase: "Song X,"

Phrase: "Elkon KB."
Processing 00000000.tx.117: Systemic exposure to irradiated apoptotic cells induces autoantibody production. 

Phrase: "Systemic exposure to irradiated apoptotic cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "autoantibody production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.118: J Exp Med 1998;188:38792.[Abstract/Free FullText] Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. 

Phrase: "J Exp Med 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";188"

Phrase: ":"

Phrase: "38792."

Phrase: "[Abstract/Free FullText"

Phrase: "] Watanabe-Fukunaga R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Brannan CI,"

Phrase: "Copeland NG,"

Phrase: "Jenkins NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Nagata S."
Processing 00000000.tx.119: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. 

Phrase: "Lymphoproliferation disorder in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012634:Disorder [Disease or Syndrome]

Phrase: "explained by defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0243067:defects [Functional Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in Fas antigen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0245662:fas Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1539477:FAS ANTIGEN [Gene or Genome]
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.120: Nature 1992;356:3147.[CrossRef][ISI][Medline] Russell JH, Rush B, Weaver C, Wang R. 

Phrase: "Nature 1992"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ";356"

Phrase: ":"

Phrase: "3147."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Russell JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Rush B,"

Phrase: "Weaver C,"

Phrase: "Wang R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.121: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. 

Phrase: "Mature T cells of autoimmune lpr/lpr mice"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C1513029:Mature T-Cell [Cell]
   770   C0039194:T-Cells [Cell]
   760   C1522131:Mouse T Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a defect in antigen-stimulated suicide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.122: Proc Natl Acad Sci USA 1993;90:440913.[Abstract/Free FullText] Cheng J, Zhou T, Liu C et al. 

Phrase: "Proc Natl Acad Sci USA 1993"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "440913."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cheng J,"

Phrase: "Zhou T,"

Phrase: "Liu C et al."
Processing 00000000.tx.123: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. 

Phrase: "Protection from Fas-mediated apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "by a soluble form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of the Fas molecule."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.124: Science 1994;263:175962.[ISI][Medline] Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ. 

Phrase: "Science 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";263"

Phrase: ":"

Phrase: "175962."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Potter PK,"

Phrase: "Cortes-Hernandez J,"

Phrase: "Quartier P,"

Phrase: "Botto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Walport MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.125: Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. 

Phrase: "Lupus-prone mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "an abnormal response to thioglycolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0039899:Thioglycolate [Organic Chemical]
   812   C3503279:thioglycolate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "an impaired clearance of apoptotic cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1523908:apoptotic cell clearance [Cell Function]
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.126: J Immunol 2003;170:322332.[Abstract/Free FullText] Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH. 

Phrase: "J Immunol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";170"

Phrase: ":"

Phrase: "322332."

Phrase: "[Abstract/Free FullText"

Phrase: "] Licht R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dieker JW,"

Phrase: "Jacobs CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Tax WJ,"

Phrase: "Berden JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.127: Decreased phagocytosis of apoptotic cells in diseased SLE mice. 

Phrase: "Decreased phagocytosis of apoptotic cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1371834:Decreased Phagocytosis [Cell Function]
   781   C2936268:Cell Phagocytosis [Cell Function]
   760   C0031308:Phagocytosis [Cell Function]

Phrase: "in diseased SLE mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   717   C2984317:Systemic lupus erythematosus [Functional Concept]
Processing 00000000.tx.128: J Autoimmun 2004;22:13945.[CrossRef][ISI][Medline] Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. 

Phrase: "J Autoimmun 2004"

Phrase: ";22"

Phrase: ":"

Phrase: "13945."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herrmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Voll RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Zoller OM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028971:OM [Geographic Area]
   861   C1705272:OM [Idea or Concept]

Phrase: "Hagenhofer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ponner BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Kalden JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.129: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. 

Phrase: "Impaired phagocytosis of apoptotic cell material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0398740:Impaired phagocytosis [Cell or Molecular Dysfunction]
   783   C2936268:Cell Phagocytosis [Cell Function]
   753   C0031308:Phagocytosis [Cell Function]

Phrase: "by monocyte-derived macrophages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024432:Monocyte-Derived Macrophages [Cell]
           Macrophages
   827   C1546706:Macrophages [Intellectual Product]
   827   C1550652:Macrophages [Body Substance]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.130: Arthritis Rheum 1998;41:124150.[CrossRef][ISI][Medline] Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. 

Phrase: "Arthritis Rheum 1998"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";41"

Phrase: ":"

Phrase: "124150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perniok A,"

Phrase: "Wedekind F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Herrmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Specker C,"

Phrase: "Schneider M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.131: High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. 

Phrase: "High levels of circulating early apoptic peripheral blood mononuclear cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.132: Lupus 1998;7:1138.[CrossRef][ISI][Medline] Emlen W, Niebur J, Kadera R. 

Phrase: "Lupus 1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024131:Lupus [Disease or Syndrome]
   861   C0024138:lupus [Disease or Syndrome]
   861   C0409974:Lupus [Disease or Syndrome]

Phrase: ";7"

Phrase: ":"

Phrase: "1138."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Emlen W,"

Phrase: "Niebur J,"

Phrase: "Kadera R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.133: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. 

Phrase: "Accelerated in vitro apoptosis of lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1518060:lymphocyte apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.134: J Immunol 1994;152:368592.[Abstract/Free FullText] Tao D, Shangwu L, Qun W et al. 

Phrase: "J Immunol 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";152"

Phrase: ":"

Phrase: "368592."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tao D,"

Phrase: "Shangwu L,"

Phrase: "Qun W et al."
Processing 00000000.tx.135: CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. 

Phrase: "CD226 expression deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "high sensitivity to apoptosis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1441604:High sensitivity [Laboratory Procedure]
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1299351:High [Qualitative Concept]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "in NK T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0022688:NK Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.136: J Immunol 2005;174:128190.[Abstract/Free FullText] Scott RS, McMahon EJ, Pop SM et al. 

Phrase: "J Immunol 2005"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";174"

Phrase: ":"

Phrase: "128190."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scott RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "McMahon EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Pop SM et al."
Processing 00000000.tx.137: Phagocytosis and clearance of apoptotic cells is mediated by MER. 

Phrase: "Phagocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]

Phrase: "and"

Phrase: "clearance of apoptotic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   870   C1523908:apoptotic cell clearance [Cell Function]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "mediated by MER."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.138: Nature 2001;411:20711.[CrossRef][ISI][Medline] Cohen PL, Caricchio R, Abraham V et al. 

Phrase: "Nature 2001"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ";411"

Phrase: ":"

Phrase: "20711."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cohen PL,"

Phrase: "Caricchio R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Abraham V et al."
Processing 00000000.tx.139: Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. 

Phrase: "Delayed apoptotic cell clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1523908:apoptotic cell clearance [Cell Function]
   812   C0449297:Clearance [Qualitative Concept]
   812   C1382187:Clearance [Clinical Attribute]
   812   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "lupus-like autoimmunity in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004368:Autoimmunity [Pathologic Function]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the c-mer membrane tyrosine kinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.140: J Exp Med 2002;196:13540.[Abstract/Free FullText] Mevorach D. 

Phrase: "J Exp Med 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";196"

Phrase: ":"

Phrase: "13540."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mevorach D."
Processing 00000000.tx.141: Opsonization of apoptotic cells. 

Phrase: "Opsonization of apoptotic cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1159762:opsonization [Cell Function]
Processing 00000000.tx.142: Implications for uptake and autoimmunity. 

Phrase: "Implications for uptake"

Phrase: "and"

Phrase: "autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.143: Ann N Y Acad Sci 2000;926:22635.[Abstract/Free FullText] Bickerstaff MCM, Botto M, Hutchinson W et al. 

Phrase: "Ann N Y Acad Sci 2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";926"

Phrase: ":"

Phrase: "22635."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bickerstaff MCM,"

Phrase: "Botto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hutchinson W et al."
Processing 00000000.tx.144: Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. 

Phrase: "Serum amyloid P component"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0002721:Serum Amyloid P-Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P Component
           Amyloid P
  1000   C1456795:AMYLOID P COMPONENT, SERUM [Gene or Genome]
           SERUM AMYLOID P
   923   C0443856:Serum amyloid P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0607063:serum P-component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002723:serum amyloid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0229671:Serum [Body Substance]
   812   C0449432:Component [Manufactured Object]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1705248:Component [Conceptual Entity]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "chromatin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "antinuclear autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004368:Autoimmunity [Pathologic Function]
   789 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.145: Nat Med 1999;5:6947.[CrossRef][ISI][Medline] Bijl M, Horst G, Bijzet J, Bootsma H, Limburg PC, Kallenberg CG. 

Phrase: "Nat Med 1999"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "6947."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bijl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Horst G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bijzet J,"

Phrase: "Bootsma H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Limburg PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Kallenberg CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]
Processing 00000000.tx.146: Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. 

Phrase: "Serum amyloid P component"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0002721:Serum Amyloid P-Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P Component
           Amyloid P
  1000   C1456795:AMYLOID P COMPONENT, SERUM [Gene or Genome]
           SERUM AMYLOID P
   923   C0443856:Serum amyloid P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0607063:serum P-component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002723:serum amyloid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0229671:Serum [Body Substance]
   812   C0449432:Component [Manufactured Object]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1705248:Component [Conceptual Entity]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to late apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "their uptake by monocyte-derived macrophages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.147: Arthritis Rheum 2003;48:24854.[CrossRef][ISI][Medline] Botto M, Dell'Agnola C, Bygrave AE et al. 

Phrase: "Arthritis Rheum 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";48"

Phrase: ":"

Phrase: "24854."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Botto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dell'Agnola C,"

Phrase: "Bygrave AE et al."
Processing 00000000.tx.148: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. 

Phrase: "Homozygous C1q deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C3150902:C1q DEFICIENCY [Finding]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "glomerulonephritis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017658:Glomerulonephritis [Disease or Syndrome]

Phrase: "associated with multiple apoptotic bodies."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C3269134:apoptotic body [Cell Component]
   760   C0242821:bodies [Human]
   760   C0439064:Multiple [Quantitative Concept]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1268086:Body [Anatomical Structure]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.149: Nat Genet 1998;19:569.[CrossRef][ISI][Medline] Gilkeson GS, Pippen AM, Pisetsky DS. 

Phrase: "Nat Genet 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";19"

Phrase: ":"

Phrase: "569."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gilkeson GS,"

Phrase: "Pippen"

Phrase: "AM"

Phrase: ","

Phrase: "Pisetsky DS."
Processing 00000000.tx.150: Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. 

Phrase: "Induction of cross-reactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "anti-dsDNA antibodies"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   864   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   855 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   853   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   837   C0919679:double stranded dna antibody [Laboratory Procedure]
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1262035:antibodies dna [Laboratory Procedure]
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in preautoimmune NZB/NZW mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0025926:Mice, NZB [Mammal]
   827   C1513867:NZW Mouse [Mammal]
           NZW
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with bacterial DNA."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]
Processing 00000000.tx.151: J Clin Invest 1995;95:1398402.[ISI][Medline] Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "1995"

Phrase: ";95"

Phrase: ":"

Phrase: "1398402."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gilkeson GS,"

Phrase: "Grudier JP,"

Phrase: "Karounos DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Pisetsky DS."
Processing 00000000.tx.152: Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. 

Phrase: "Induction of anti-double stranded DNA antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in normal mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with bacterial DNA."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]
Processing 00000000.tx.153: J Immunol 1989;142:14826.[Abstract/Free FullText] Onishi Y, Kato M, Hanyu Y. 

Phrase: "J Immunol 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";142"

Phrase: ":"

Phrase: "14826."

Phrase: "[Abstract/Free FullText"

Phrase: "] Onishi Y,"

Phrase: "Kato M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hanyu Y."
Processing 00000000.tx.154: Preparation and characterization of an anti-DNA monoclonal antibody showing size selectivity toward DNA fragments. 

Phrase: "Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "characterization of an anti-DNA monoclonal antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "size selectivity toward DNA fragments."
Processing 00000000.tx.155: Hybrid Hybridomics 2004;23:3117.[CrossRef][ISI][Medline] Richardson B, Ray D, Yung R. 

Phrase: "Hybrid Hybridomics 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020205:Hybrid [Organism]

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "3117."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richardson B,"

Phrase: "Ray D,"

Phrase: "Yung R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.156: Murine models of lupus induced by hypomethylated T cells. 

Phrase: "Murine models of lupus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Models [Intellectual Product]

Phrase: "induced by hypomethylated T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0039194:T-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205263:Induced [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.157: Methods Mol Med 2004;102:28594.[Medline] Wang D, Kandimalla ER, Yu D, Tang JX, Agrawal S. 

Phrase: "Methods Mol Med 2004"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C0449851:Methods [Functional Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   779 E C0871511:METHOD [Intellectual Product]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";102"

Phrase: ":"

Phrase: "28594."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang D,"

Phrase: "Kandimalla ER,"

Phrase: "Yu D,"

Phrase: "Tang JX,"

Phrase: "Agrawal S."
Processing 00000000.tx.158: Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity. 

Phrase: "Oral administration of second-generation immunomodulatory oligonucleotides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0001563:Administration, Oral [Therapeutic or Preventive Procedure]
   748   C0001554:Administration [Occupational Activity]
   748   C0442027:Oral [Spatial Concept]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mucosal Th1 immune responses"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C0282557:Mucosal Immune Responses [Organ or Tissue Function]
   906   C1155080:Th1 immune response [Cell Function]
   861   C0301872:immune responses [Organ or Tissue Function]
   812   C0439662:Immune [Functional Concept]
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "adjuvant activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.159: Vaccine 2005;23:261422.[CrossRef][ISI][Medline] Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. 

Phrase: "Vaccine 2005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042210:Vaccine [Immunologic Factor,Pharmacologic Substance]
   861   C1552558:Vaccine [Intellectual Product]

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "261422."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krieg"

Phrase: "AM"

Phrase: ","

Phrase: "Yi AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Matson S,"

Phrase: "Waldschmidt TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Bishop GA,"

Phrase: "Teasdale R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Koretzky GA,"

Phrase: "Klinman DM."
Processing 00000000.tx.160: CpG motifs in bacterial DNA trigger direct B-cell activation. 

Phrase: "CpG motifs in bacterial DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3178798:DNA Motifs [Nucleotide Sequence]
   726   C1514562:Motif [Amino Acid Sequence]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "direct B-cell activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155003:B-Cell Activation [Cell Function]
   923   C1332420:B-cell activation [Gene or Genome]
   861   C1326120:cell activation [Cell Function]
   812   C1879547:Activation [Activity]
Processing 00000000.tx.161: Nature 1995;374:5469.[CrossRef][ISI][Medline] Hemmi H, Takeuchi O, Kawai T et al. 

Phrase: "Nature 1995"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ";374"

Phrase: ":"

Phrase: "5469."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hemmi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takeuchi O,"

Phrase: "Kawai T et al."
Processing 00000000.tx.162: A Toll-like receptor recognizes bacterial DNA. 

Phrase: "A Toll-like receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: "recognizes"

Phrase: "bacterial DNA."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]
Processing 00000000.tx.163: Nature 2000;408:7405.[CrossRef][ISI][Medline] Takeshita F, Leifer CA, Gursel I et al. 

Phrase: "Nature 2000"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ";408"

Phrase: ":"

Phrase: "7405."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takeshita F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Leifer CA,"

Phrase: "Gursel I et al."
Processing 00000000.tx.164: Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. 

Phrase: "Cutting edge"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   861   C0205154:Edge [Spatial Concept]
   861   C1306235:Cutting [Qualitative Concept]
   861   C2697523:Edge [Conceptual Entity]
   861   C3496294:Cutting [Functional Concept]
   827 E C0000925:Cut [Injury or Poisoning]
   827 E C1883724:CUT [Phenomenon or Process]

Phrase: ":"

Phrase: "Role of Toll-like receptor 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   716   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   716   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]

Phrase: "in CpG DNA-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of human cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.165: J Immunol 2001;167:35558.[Abstract/Free FullText] Bauer S, Kirschning CJ, Hacker H et al. 

Phrase: "J Immunol 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";167"

Phrase: ":"

Phrase: "35558."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bauer S,"

Phrase: "Kirschning CJ,"

Phrase: "Hacker H et al."
Processing 00000000.tx.166: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. 

Phrase: "Human TLR9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1423633:TLR9 [Gene or Genome]

Phrase: "confers"

Phrase: "responsiveness to bacterial DNA"

Phrase: "via species-specific CpG motif recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0524637:Recognition [Mental Process]
Processing 00000000.tx.167: Proc Natl Acad Sci USA 2001;98:923742.[Abstract/Free FullText] Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. 

Phrase: "Proc Natl Acad Sci USA 2001"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";98"

Phrase: ":"

Phrase: "923742."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yi AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Chang M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Peckham DW,"

Phrase: "Krieg"

Phrase: "AM"

Phrase: ","

Phrase: "Ashman RF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]
Processing 00000000.tx.168: CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. 

Phrase: "CpG oligodeoxyribonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028948:Oligodeoxyribonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "rescue"

Phrase: "mature spleen B cells from spontaneous apoptosis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   819   C1819913:mature B cell apoptosis [Cell Function]
   788   C1326202:B cell apoptosis [Cell Function]
   788   C1513019:Mature B-Cell [Cell]
   778   C0004561:B-Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell cycle entry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1705654:Entry [Intellectual Product]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]
Processing 00000000.tx.169: J Immunol 1998;160:5898906.[Abstract/Free FullText] Lener P, George A, Handwerger BS, Ashman RF. 

Phrase: "J Immunol 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";160"

Phrase: ":"

Phrase: "5898906."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lener P,"

Phrase: "George A,"

Phrase: "Handwerger BS,"

Phrase: "Ashman RF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]
Processing 00000000.tx.170: Innate immune response in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides. 

Phrase: "Innate immune response in lupus-prone Palmerston North mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   764   C0301872:Immune response [Organ or Tissue Function]
   742   C0439662:Immune [Functional Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "differential responses to LPS"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   898   C1819415:response to LPS [Organism Function]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "bacterial DNA/CpG oligonucleotides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0914670:CPG-oligonucleotide [Amino Acid, Peptide, or Protein]
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.171: J Clin Immunol 2003;23:20213.[CrossRef][ISI][Medline] Brummel R, Lenert P. 

Phrase: "J Clin Immunol 2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "20213."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brummel R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lenert P."
Processing 00000000.tx.172: Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. 

Phrase: "Activation of marginal zone B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1155003:B-Cell Activation [Cell Function]
   804   C1332420:B-cell activation [Gene or Genome]
   783   C1326120:activation cells [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "from lupus mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with type A("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "D)"

Phrase: "CpG-oligodeoxynucleotides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.173: J Immunol 2005;174:242934[Abstract/Free FullText] Ehrenstein MR, Katz DR, Griffiths MH et al. 

Phrase: "J Immunol 2005"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";174"

Phrase: ":"

Phrase: "242934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ehrenstein MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Katz DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Griffiths MH et al."
Processing 00000000.tx.174: Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. 

Phrase: "Human IgG anti-DNA antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   884   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   858   C2754943:IgG antibody [Cell Component]
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   823   C1262035:dna antibody [Laboratory Procedure]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "deposit in kidneys"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   790   C0227665:kidneys [Body Part, Organ, or Organ Component]
   790   C0333562:Deposit [Functional Concept]
   756 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   756 E C1514845:KIDNEY [Tissue]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "proteinuria in SCID mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0240817:Proteinuria, severe [Finding]
   753   C0033687:Proteinuria [Finding]
   753   C1962972:Proteinuria [Finding]
   716   C0085112:Severe Combined Immunodeficient Mice [Mammal]
Processing 00000000.tx.175: Kidney Int 1995;48:70511.[ISI][Medline] Mason LJ, Ravirajan CT, Latchman DS, Isenberg DA. 

Phrase: "Kidney Int 1995"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";48"

Phrase: ":"

Phrase: "70511."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mason LJ,"

Phrase: "Ravirajan CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Latchman DS,"

Phrase: "Isenberg DA."
Processing 00000000.tx.176: A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of leaky SCID mice. 

Phrase: "A human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "anti-dsDNA monoclonal antibody"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   855   C2746079:Anti-Double Stranded DNA Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   838 E C0312612:Double stranded anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Double-stranded DNA antibody
   833   C2698136:Anti-Double Stranded DNA [Laboratory Procedure]
   822   C0919679:double stranded dna antibody [Laboratory Procedure]
   800   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   789   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1262035:antibody dna [Laboratory Procedure]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205173:Double [Functional Concept]
   744   C0746619:monoclonal [Finding]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   735   C1979882:Double strand [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "hyaline thrombi formation in kidneys of leaky SCID mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220781:formation [Biologic Function]
   738   C0439634:formation [Spatial Concept]
   738   C1522492:Formation [Functional Concept]
Processing 00000000.tx.177: Clin Exp Immunol 2001;126:13742.[CrossRef][ISI][Medline] Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. 

Phrase: "Clin Exp Immunol 2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";126"

Phrase: ":"

Phrase: "13742."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zack DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Stempniak M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wong AL,"

Phrase: "Taylor C,"

Phrase: "Weisbart RH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]
Processing 00000000.tx.178: Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. 

Phrase: "Mechanisms of cellular penetration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "nuclear localization of an anti-double strand DNA autoantibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
Processing 00000000.tx.179: J Immunol 1996;157:20828.[Abstract] Reichlin M. 

Phrase: "J Immunol 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";157"

Phrase: ":"

Phrase: "20828."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Reichlin M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.180: Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. 

Phrase: "Cellular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "induced by penetration of autoantibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205263:Induced [Functional Concept]
   760   C0205321:Penetration [Functional Concept]

Phrase: "into living cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "cellular damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0031847:dysfunction [Functional Concept]
  1000   C0277785:Dysfunction, NOS [Qualitative Concept]
   944 E C0231174:Malfunction [Functional Concept]
   944 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "mediated by antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ribosomal P proteins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896 E C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1441153:Ribosomal P [Immunologic Factor]
Processing 00000000.tx.181: J Autoimmunity 1998;11:55761.[CrossRef][ISI][Medline] Lee HB, Diamond BA, Blaufox MD. 

Phrase: "J Autoimmunity 1998"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004368:Autoimmunity [Pathologic Function]
   755 E C0443146:Autoimmune [Pathologic Function]

Phrase: ";11"

Phrase: ":"

Phrase: "55761."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee HB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Hb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Diamond BA,"

Phrase: "Blaufox MD."
Processing 00000000.tx.182: In vivo detection of deposition of radiolabeled lupus anti-kidney antibody and its inhibition by soluble antigen. 

Phrase: "In vivo detection of deposition of radiolabeled lupus anti-kidney antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0430425:Antibody detection [Laboratory Procedure]
   738   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its inhibition by soluble antigen."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.183: J Nucl Med 2001;42:13840.[Abstract/Free FullText] Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. 

Phrase: "J Nucl Med 2001"

Phrase: ";42"

Phrase: ":"

Phrase: "13840."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gaynor B,"

Phrase: "Putterman C,"

Phrase: "Valadon P,"

Phrase: "Spatz L,"

Phrase: "Scharff MD,"

Phrase: "Diamond B."
Processing 00000000.tx.184: Peptide inhibition of glomerular deposition of an anti-DNA antibody. 

Phrase: "Peptide inhibition of glomerular deposition of an anti-DNA antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.185: Proc Natl Acad Sci USA 1997;94:195560.[Abstract/Free FullText] Putterman C, Diamond B. 

Phrase: "Proc Natl Acad Sci USA 1997"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";94"

Phrase: ":"

Phrase: "195560."

Phrase: "[Abstract/Free FullText"

Phrase: "] Putterman C,"

Phrase: "Diamond B."
Processing 00000000.tx.186: Immunization with a peptide surrogate for dsDNA induces autoantibody production and renal immunoglobulin deposition. 

Phrase: "Immunization with a peptide surrogate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C3244291:immunization [Functional Concept]

Phrase: "for dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "autoantibody production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "renal immunoglobulin deposition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1512663:Immunoglobulin Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.187: J Exp Med 1998;188:2938.[Abstract/Free FullText] Mostoslavsky G, Fischel R, Yachimovich N et al. 

Phrase: "J Exp Med 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";188"

Phrase: ":"

Phrase: "2938."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mostoslavsky G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Fischel R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yachimovich N et al."
Processing 00000000.tx.188: Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. 

Phrase: "Lupus anti-DNA autoantibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cross-react with a glomerular structural protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0582263:Structural protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0268731:GLOMERULAR [Disease or Syndrome]
   748   C0678594:Structural [Spatial Concept]
   748   C2828360:Cross [Conceptual Entity]

Phrase: ":"

Phrase: "a case for tissue injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "by molecular mimicry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242943:Molecular Mimicry [Molecular Function]
   861   C0233577:Mimicry [Mental or Behavioral Dysfunction]
Processing 00000000.tx.189: Eur J Immunol 2001;31:12217.[CrossRef][ISI][Medline] Deocharan B, Qing X, Lichauco J, Putterman C. 

Phrase: "Eur J Immunol 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "12217."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Deocharan B,"

Phrase: "Qing X,"

Phrase: "Lichauco J,"

Phrase: "Putterman C."
Processing 00000000.tx.190: Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. 

Phrase: "Alpha-actinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0917705:alpha-Actinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001245:Actinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a cross-reactive renal target for pathogenic anti-DNA antibodies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1521840:Target [Functional Concept]
   739   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.191: J Immunol 2002;168:30728.[Abstract/Free FullText] DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. 

Phrase: "J Immunol 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";168"

Phrase: ":"

Phrase: "30728."

Phrase: "[Abstract/Free FullText"

Phrase: "] DeGiorgio LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Konstantinov KN,"

Phrase: "Lee SC,"

Phrase: "Hardin JA,"

Phrase: "Volpe BT,"

Phrase: "Diamond B."
Processing 00000000.tx.192: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. 

Phrase: "A subset of lupus anti-DNA antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "cross-reacts with the NR2 glutamate receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   748   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C2828360:Cross [Conceptual Entity]

Phrase: "in systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.193: Nat Med 2001;7:118993.[CrossRef][ISI][Medline] Jerne NK. 

Phrase: "Nat Med 2001"

Phrase: ";7"

Phrase: ":"

Phrase: "118993."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jerne NK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]
Processing 00000000.tx.194: Towards a network theory of the immune system. 

Phrase: "Towards a network theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871935:Theory [Idea or Concept]

Phrase: "of the immune system."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020962:Immune system [Body System]
  1000   C1291764:IMMUNE SYSTEM [Finding]
   861   C0439662:Immune [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.195: Ann Immunol (Paris) 1974;125c:37389. 

Phrase: "Ann Immunol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: "1974"

Phrase: ";125c"

Phrase: ":"

Phrase: "37389."
Processing 00000000.tx.196: Shoenfeld Y, Mozes E. 

Phrase: "Shoenfeld Y,"

Phrase: "Mozes E."
Processing 00000000.tx.197: Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. 

Phrase: "Pathogenic idiotypes of autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021013:idiotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: ":"

Phrase: "lessons from new experimental models of SLE."
Processing 00000000.tx.198: FASEB J 1990;4:264651.[Abstract/Free FullText] Shoenfeld Y. 

Phrase: "FASEB J 1990"

Phrase: ";4"

Phrase: ":"

Phrase: "264651."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shoenfeld Y."
Processing 00000000.tx.199: Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. 

Phrase: "Idiotypic induction of autoimmunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "a new aspect of the idiotypic network."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1547011:Aspect [Quantitative Concept]
   748   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.200: FASEB J 1994;8:1296301.[Abstract/Free FullText] Mendlovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E. 

Phrase: "FASEB J 1994"

Phrase: ";8"

Phrase: ":"

Phrase: "1296301."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mendlovic S,"

Phrase: "Brocke S,"

Phrase: "Shoenfeld Y,"

Phrase: "Ben-Bassat M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Meshorer A,"

Phrase: "Bakimer R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mozes E."
Processing 00000000.tx.201: Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. 

Phrase: "Induction of a systemic lupus erythematosus-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "like disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "by a common human anti-DNA idiotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.202: Proc Natl Acad Sci USA 1988;85:22604.[Abstract/Free FullText] Eilat E, Dayan M, Zinger H, Mozes E. 

Phrase: "Proc Natl Acad Sci USA 1988"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";85"

Phrase: ":"

Phrase: "22604."

Phrase: "[Abstract/Free FullText"

Phrase: "] Eilat E,"

Phrase: "Dayan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zinger H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mozes E."
Processing 00000000.tx.203: The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. 

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "based on complementarity-determining region-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0887926:Complementarity Determining Region 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0021024:Complementarity-Determining Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "of a pathogenic anti-DNA auto-Ab"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1441488:Auto [Laboratory Procedure]

Phrase: "ameliorates"

Phrase: "experimental systemic lupus erythematosus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   923   C2984317:Systemic lupus erythematosus [Functional Concept]
   861   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   812   C0024131:Lupus [Disease or Syndrome]
   812   C0024138:lupus [Disease or Syndrome]
   812   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.204: Proc Natl Acad Sci USA 2001;98:114853.[Abstract/Free FullText] Dang H, Ogawa N, Takei M, Lazaridis K, Talal N. 

Phrase: "Proc Natl Acad Sci USA 2001"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";98"

Phrase: ":"

Phrase: "114853."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ogawa N,"

Phrase: "Takei M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lazaridis K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Talal N."
Processing 00000000.tx.205: Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. 

Phrase: "Induction of lupus-associated autoantibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "recombinant Ig polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "expressing"

Phrase: "a cross-reactive idiotype 4B4."
Processing 00000000.tx.206: J Immunol 1993;151:72607.[Abstract/Free FullText] Tincani A, Balestrieri G, Allegri F et al. 

Phrase: "J Immunol 1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";151"

Phrase: ":"

Phrase: "72607."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tincani A,"

Phrase: "Balestrieri G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Allegri F et al."
Processing 00000000.tx.207: Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 

Phrase: "Induction of experimental SLE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in naive mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with human polyclonal anti-DNA antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   875   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1262035:dna antibody [Laboratory Procedure]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the 16/6 idiotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.208: Clin Exp Rheumatol 1993;11:12934.[ISI][Medline] Satake F, Watanabe N, Miyasaka N, Kanai Y, Kubota T. 

Phrase: "Clin Exp Rheumatol 1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]

Phrase: ";11"

Phrase: ":"

Phrase: "12934."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Satake F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Watanabe N,"

Phrase: "Miyasaka N,"

Phrase: "Kanai Y,"

Phrase: "Kubota T."
Processing 00000000.tx.209: Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: mechanism and characterization. 

Phrase: "Induction of anti-DNA antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with anti-DNA antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0282056:Antibodies, Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1262035:dna antibody [Laboratory Procedure]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "characterization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]
Processing 00000000.tx.210: Lupus 2000;9:48997.[ISI][Medline] Rombach E, Stetler DA, Brown JC. 

Phrase: "Lupus 2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024131:Lupus [Disease or Syndrome]
   861   C0024138:lupus [Disease or Syndrome]
   861   C0409974:Lupus [Disease or Syndrome]

Phrase: ";9"

Phrase: ":"

Phrase: "48997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rombach E,"

Phrase: "Stetler DA,"

Phrase: "Brown JC."
Processing 00000000.tx.211: Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody. 

Phrase: "Induction of an anti-Fab,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "anti-DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "anti-RNA polymerase I autoantibody response network in rabbits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1513822:Network [Professional or Occupational Group]
   742   C1705739:Network [Manufactured Object]
   742   C1882071:Network [Conceptual Entity]

Phrase: "immunized with SLE anti-DNA antibody."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   800   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   800   C2984317:Systemic lupus erythematosus [Functional Concept]
   770   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   770   C1262035:dna antibody [Laboratory Procedure]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0443794:Lupus antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0024131:Lupus [Disease or Syndrome]
   744   C0024138:lupus [Disease or Syndrome]
   744   C0205373:Systemic [Functional Concept]
Processing 00000000.tx.212: Clin Exp Immunol 1993;94:46672.[ISI][Medline] Isenberg DA, Katz D, Le Page S et al. 

Phrase: "Clin Exp Immunol 1993"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";94"

Phrase: ":"

Phrase: "46672."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Isenberg DA,"

Phrase: "Katz D,"

Phrase: "Le Page S et al."
Processing 00000000.tx.213: Independent analysis of the 16/6 idiotype lupus model. 

Phrase: "Independent analysis of the 16/6 idiotype lupus model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.214: A role for an environmental factor? 

Phrase: "A role for an environmental factor?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.215: J Immunol 1991;147:41727.[Abstract/Free FullText] Shoenfeld Y. 

Phrase: "J Immunol 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";147"

Phrase: ":"

Phrase: "41727."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shoenfeld Y."
Processing 00000000.tx.216: The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies. 

Phrase: "The idiotypic network in autoimmunity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: ":"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.217: Nat Med 2004;10:178.[CrossRef][ISI][Medline] Ye YL, Chiang BL. 

Phrase: "Nat Med 2004"

Phrase: ";10"

Phrase: ":"

Phrase: "178."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ye YL,"

Phrase: "Chiang BL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]
Processing 00000000.tx.218: Reconstitution of severe combined immunodeficient mice with spleen cells from autoimmune NZBxNZW F1 mice. 

Phrase: "Reconstitution of severe combined immunodeficient mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0085112:Severe Combined Immunodeficient Mice [Mammal]

Phrase: "with spleen cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0007634:Cells [Cell]
   861   C0037993:Spleen [Body Part, Organ, or Organ Component]
   861   C0771377:SPLEEN [Tissue]
   861   C1278932:Spleen [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from autoimmune NZBxNZW F1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.219: Clin Exp Rheumatol 1998;16:337.[ISI][Medline] Sthoeger Z, Zinger H, Dekel B, Arditi F, Reisner Y, Mozes E. 

Phrase: "Clin Exp Rheumatol 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]

Phrase: ";16"

Phrase: ":"

Phrase: "337."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sthoeger Z,"

Phrase: "Zinger H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dekel B,"

Phrase: "Arditi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Reisner Y,"

Phrase: "Mozes E."
Processing 00000000.tx.220: Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras. 

Phrase: "Lupus manifestations in severe combined immunodeficient (SCID) mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205319:manifestations [Functional Concept]
   748   C1280464:manifestations [Qualitative Concept]

Phrase: "and in human/mouse radiation chimeras."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   790   C0034523:Radiation Chimeras [Organism]
   773 E C1318486:Radiation chimera [Disease or Syndrome]
   753   C0008109:Chimeras [Organism]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0034519:Radiation [Natural Phenomenon or Process]
   753   C0086418:Human [Human]
   753   C0560559:Radiation [Quantitative Concept]
   753   C0851346:Radiation [Natural Phenomenon or Process]
   753   C1515981:And [Idea or Concept]
   753   C1522449:Radiation [Therapeutic or Preventive Procedure]
   753   C1524020:Radiation [Therapeutic or Preventive Procedure]
   753   C1524021:Radiation [Research Activity]
   719 E C1318484:Chimera [Disease or Syndrome]
Processing 00000000.tx.221: J Clin Immunol 2003;23:919.[CrossRef][ISI][Medline] Mauermann N, Sthoeger Z, Zinger H, Mozes E. 

Phrase: "J Clin Immunol 2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "919."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mauermann N,"

Phrase: "Sthoeger Z,"

Phrase: "Zinger H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mozes E."
Processing 00000000.tx.222: Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients. 

Phrase: "Amelioration of lupus manifestations"

Phrase: "by a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "based on the complementarity determining region 1 of an autoantibody"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0887926:Complementarity Determining Region 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   782   C0021024:Complementarity-Determining Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0004358:Autoantibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in severe combined immunodeficient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   976   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]
   865   C0494261:Combined immunodeficiencies [Disease or Syndrome]
   827   C0021051:Immunodeficient [Disease or Syndrome]

Phrase: "(SCID"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   976   C0085110:Severe Combined Immunodeficiencies [Disease or Syndrome]
   865   C0494261:Combined immunodeficiencies [Disease or Syndrome]
   827   C0021051:Immunodeficient [Disease or Syndrome]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "engrafted with peripheral blood lymphocytes of systemic lupus erythematosus"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   790   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
   790   C2984317:Systemic lupus erythematosus [Functional Concept]
   764   C0229664:peripheral blood [Body Substance]
           Blood
   764   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   756   C1518997:Peripheral Blood Lymphocyte [Cell]
   748   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0024131:Lupus [Disease or Syndrome]
   742   C0024138:lupus [Disease or Syndrome]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0205373:Systemic [Functional Concept]
   723 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]

Phrase: "(SLE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024141:Lupus Erythematosus, Systemic [Disease or Syndrome]
  1000   C2984317:Systemic lupus erythematosus [Functional Concept]
   901   C0409974:Lupus Erythematosus [Disease or Syndrome]
           Lupus
   827   C0024131:Lupus [Disease or Syndrome]
   827   C0024138:lupus [Disease or Syndrome]
   827   C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: "patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.223: Clin Exp Immunol 2004;137:51320.[CrossRef][ISI][Medline] Limpanasithikul W, Ray S, Diamond B. 

Phrase: "Clin Exp Immunol 2004"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";137"

Phrase: ":"

Phrase: "51320."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Limpanasithikul W,"

Phrase: "Ray S,"

Phrase: "Diamond B."
Processing 00000000.tx.224: Cross-reactive antibodies have both protective and pathogenic potential. 

Phrase: "Cross-reactive antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0010357:Cross-reactive [Molecular Function]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0205332:Reactive [Qualitative Concept]
   827   C2828360:Cross [Conceptual Entity]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "both protective"

Phrase: "and"

Phrase: "pathogenic potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.225: J Immunol 1995;155:96773.[Abstract] Portis T, Ikeda M, Longnecker R. 

Phrase: "J Immunol 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";155"

Phrase: ":"

Phrase: "96773."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Portis T,"

Phrase: "Ikeda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Longnecker R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.226: Epstein-Barr virus LMP2A: regulating cellular ubiquitination processes for maintenance of viral latency? 

Phrase: "Epstein-Barr virus LMP2A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0014644:Epstein-Barr Virus [Virus]

Phrase: ":"

Phrase: "regulating"

Phrase: "cellular ubiquitination processes for maintenance of viral latency?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0007613:Cellular Process [Cell Function]
   750   C1325880:cellular process [Cell Function]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.227: Trends Immunol 2004;25:4226.[CrossRef][ISI][Medline] Pender MP. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Immunol 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";25"

Phrase: ":"

Phrase: "4226."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pender MP."
Processing 00000000.tx.228: Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. 

Phrase: "Infection of autoreactive B lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "with EBV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014644:EBV [Virus]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "chronic autoimmune diseases."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0008679:Chronic diseases [Disease or Syndrome]
   901   C0004364:Autoimmune Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   827   C0443146:Autoimmune [Pathologic Function]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.229: Trends Immunol 2003;24:5848.[CrossRef][ISI][Medline] Kuo P, Bynoe MS, Wang C, Diamond B. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Immunol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";24"

Phrase: ":"

Phrase: "5848."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuo P,"

Phrase: "Bynoe MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Wang C,"

Phrase: "Diamond B."
Processing 00000000.tx.230: Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset. 

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "leads to expression of anti-DNA B cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C0004561:B-Cells [Cell]
   770   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0007634:Cells [Cell]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "no nephritis"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0027697:Nephritis [Disease or Syndrome]
   907 E C0022646:Kidney [Body Part, Organ, or Organ Component]
   907 E C0227665:kidney [Body Part, Organ, or Organ Component]
   907 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   907 E C1514845:KIDNEY [Tissue]

Phrase: ":"

Phrase: "a model for a clinical subset."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.231: Eur J Immunol 1999;29:316878.[CrossRef][ISI][Medline] Hoyer BF, Moser K, Hauser AE et al. 

Phrase: "Eur J Immunol 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";29"

Phrase: ":"

Phrase: "316878."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoyer BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006409:BF [Geographic Area]
   861   C1824728:BF [Gene or Genome]

Phrase: "Moser K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hauser AE et al."
Processing 00000000.tx.232: Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. 

Phrase: "Short-lived plasmablasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0229657:Plasmablast [Cell]
   793   C2698870:Plasmablast [Laboratory Procedure]

Phrase: "and"

Phrase: "long-lived plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0032112:Plasma Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0032105:Plasma [Body Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "contribute to chronic humoral autoimmunity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004368:Autoimmunity [Pathologic Function]
   760   C0205191:chronic [Temporal Concept]
   760   C1880177:Contribute [Activity]

Phrase: "in NZB/W mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025926:Mice, NZB [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.233: J Exp Med 2004;199:157784.[Abstract/Free FullText] This Article Full Text (PDF) All Versions of this Article: 44/9/1086 most recent keh695v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (1) Disclaimer Request Permissions Google Scholar Articles by Blank, M. 

Phrase: "J Exp Med 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ";199"

Phrase: ":"

Phrase: "157784."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1527021:Text [Intellectual Product]
   827   C1554111:Text [Idea or Concept]
   827   C1705606:Text [Intellectual Product]
   827   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "44/9/1086 most recent keh695v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Disclaimer Request Permissions Google Scholar Articles by Blank,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.234: Articles by Shoenfeld, Y. 

Phrase: "Articles by Shoenfeld,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "Y."
Processing 00000000.tx.235: PubMed PubMed Citation Articles by Blank, M. 

Phrase: "PubMed PubMed Citation Articles by Blank,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: Articles by Shoenfeld, Y. 

Phrase: "Articles by Shoenfeld,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "Y."
Processing 00000000.tx.237: Related Collections Rheumatoid Arthritis Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Related Collections Rheumatoid Arthritis Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0037455:society [Organization]

Phrase: "for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   801   C2735290:Privacy policy [Intellectual Product]
   788   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

